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Abstract
The E3 ubiquitin ligase RNF8 (RING finger protein 8) is a pivotal
enzyme for DNA repair. However, RNF8 hyper-accumulation is
tumour-promoting and positively correlates with genome instabil-
ity, cancer cell invasion, metastasis and poor patient prognosis.
Very little is known about the mechanisms regulating RNF8 home-
ostasis to preserve genome stability. Here, we identify the cellular
machinery, composed of the p97/VCP ubiquitin-dependent unfol-
dase/segregase and the Ataxin 3 (ATX3) deubiquitinase, which
together form a physical and functional complex with RNF8 to
regulate its proteasome-dependent homeostasis under physiologi-
cal conditions. Under genotoxic stress, when RNF8 is rapidly
recruited to sites of DNA lesions, the p97–ATX3 machinery stimu-
lates the extraction of RNF8 from chromatin to balance DNA repair
pathway choice and promote cell survival after ionising radiation
(IR). Inactivation of the p97–ATX3 complex affects the non-homolo-
gous end joining DNA repair pathway and hypersensitises human
cancer cells to IR. We propose that the p97–ATX3 complex is the
essential machinery for regulation of RNF8 homeostasis under
both physiological and genotoxic conditions and that targeting
ATX3 may be a promising strategy to radio-sensitise BRCA-deficient
cancers.
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Introduction
DNA double-strand breaks (DSBs) are the most deleterious DNA
lesions and, if not accurately repaired, can lead to chromosomal
aberrations, immunodeficiency, neurodegeneration, cancer, acceler-
ated ageing and cell death (Friedberg et al, 2006; Jackson & Bartek,
2009; Panier & Durocher, 2013; Jeggo et al, 2016).
Mammalian cells execute two main DSB repair pathways: non-
homologous end joining (NHEJ) and homologous recombination
(HR), promoted by 53BP1 and BRCA1/BRCA2/Rad51, respectively
(Chapman et al, 2012; Aparicio et al, 2014; Hustedt & Durocher,
2016). The coordination of DSB repair is under the strict control of
various post-translational modifications (PTMs). These include ubiq-
uitination generated by two E3 ubiquitin ligases RNF8 and RNF168
which has emerged as an essential PTM for DSB repair pathway
choice and cell survival (Kolas et al, 2007; Mailand et al, 2007; Doil
et al, 2009; Pinato et al, 2009; Stewart et al, 2009; Gatti et al, 2015).
RNF8 is the first E3 ubiquitin ligase recruited to sites of DSBs, where
it ubiquitinates histone H1 with K63-ubiquitin-linked chains (K63-Ub)
in cooperation with the E2 ubiquitin conjugating enzyme Ubc13 (Thor-
slund et al, 2015). RNF8-dependent H1/K63-Ub is essential to recruit
the second E3 ubiquitin ligase RNF168. RNF168 further amplifies and
spreads the ubiquitin signal onto the surrounding histones, H2A-type
histones, that serve as docking sites for 53BP1 recruitment to chro-
matin to prevent excessive 50-DNA end resection (the initial step of the
HR pathway) and to promote NHEJ-mediated repair (Mattiroli et al,
2012; Chang et al, 2017; Dev et al, 2018; Noordermeer et al, 2018).
BRCA1 and Rad51, the essential enzymes for HR, are also recruited
to sites of DSBs in a ubiquitin-dependent manner; however, their
recruitment is strictly dependent on RNF8 and not RNF168 (Kim et al,
2007; Sobhian et al, 2007; Wang & Elledge, 2007; Sy et al, 2011;
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Munoz et al, 2012; Nakada et al, 2012; Watanabe et al, 2013; Zong
et al, 2019), supporting the notion that HR is not absolutely dependent
on the RNF168-mediated ubiquitin signalling cascade.
Separation of function between these two main DSB repair E3
ubiquitin ligases—RNF8 and RNF168—was further observed in
RIDDLE syndrome patient cells bearing RNF168 mutations. These
cells are radiosensitive due to their inability to recruit 53BP1 (NHEJ
pathway) to sites of DSBs, while maintaining recruitment of BRCA1
and Rad51 (HR pathway) to the break sites (Stewart et al, 2007).
This was also confirmed in the Rnf168-knockout mouse cells (Zong
et al, 2019). Finally, structural and cell biological data further
demonstrate an independent and direct role of RNF8 and its K63-Ub
in BRCA1 recruitment to sites of DNA lesions (Hodge et al, 2016).
Altogether this suggests that the RNF168/Ubiquitin/53BP1
cascade is essential to mediate NHEJ and is functionally distin-
guished from the RNF8/K63-Ub/BRCA1/Rad51-governed HR repair
pathway. Thus, to have balanced DSB repair, the levels of RNF8
and RNF168 have to be tightly regulated.
Unlike RNF168, whose protein expression is tightly regulated by
two E3 ubiquitin ligases and a deubiquitinating enzyme (DUB), namely
UBR5, TRIP12 and USP7, respectively (Gudjonsson et al, 2012; Zhu
et al, 2015), how the homeostasis of RNF8 is regulated is not known.
This is a key issue, not only for accurate DNA repair after genotoxic
stress but also for genome stability under physiological conditions,
since hyper-accumulation of RNF8 is directly linked to tumorigenesis
and poor prognosis in breast cancer patients (Kuang et al, 2016; Lee
et al, 2016a,b). Here, we present data demonstrating that RNF8 home-
ostasis is regulated by the ATPase p97 (p97)—also known as VCP
unfoldase in humans—and its associated DUB Ataxin 3 (ATX3).
The AAA+ ATPase p97 is a homo-hexameric barrel-like protein,
which forms multiple complexes and sub-complexes with its associ-
ated cofactors that confer p97 specificity to various substrates and
cellular pathways (Meyer & Weihl, 2014; Buchberger et al, 2015).
These p97 complexes bind (via cofactors) and process (via p97 ATPase
activity) ubiquitinated substrates by either unfolding or segregating
them from different cellular locations including chromatin (Vaz et al,
2013; Dantuma et al, 2014). In turn, ubiquitinated substrates remod-
elled by the p97 system are either presented to the proteasome for their
degradation or recycled by DUBs (Meyer et al, 2012). Thus, the p97
system plays a central role in maintaining protein homeostasis.
Here, we report that p97 and ATX3 (Rao et al, 2017) form a consti-
tutive physical complex with RNF8. The p97–ATX3 complex safe-
guards the soluble pool of RNF8 under physiological conditions.
However, under genotoxic conditions, when RNF8 is rapidly recruited
to sites of DNA lesions and orchestrates the DNA damage response, the
p97–ATX3 complex facilitates RNF8 chromatin extraction to balance
DSB repair pathway choice and improve cell survival to ionising radia-
tion (IR). Our data reveal the p97–ATX3 complex as a crucial mediator
of RNF8 regulation and identify a fundamental role of the p97–ATX3–
RNF8 axis in promoting genome stability and resistance to IR.
Results
RNF8 is a ubiquitinated substrate of p97
To test the hypothesis that the p97 system regulates RNF8 homeosta-
sis, we monitored the total pool of endogenous RNF8 in HeLa and
HEK293 cells when either p97 was siRNA-depleted or its ATPase
activity was blocked. The ATPase activity of p97 was blocked by
either acute chemical inhibition (CB5083) or doxycycline (DOX)-indu-
cible expression of the p97E578Q (p97EQ; dominant negative) vari-
ant. Inactivation of p97 by either approach led to increased total
levels of endogenous RNF8 under physiological and IR-treated condi-
tions (Fig 1A–F). Both chemically inhibited p97 and the p97EQ vari-
ant bind, but are unable to process, the substrates due to inactivation
of p97 ATPase activity (Ye et al, 2003; Meerang et al, 2011; Fig 1G).
Similarly, cycloheximide (CHX) chase experiments in p97-inactivated
HEK293 cells, either by siRNA-mediated p97 depletion or by mild
expression of p97EQ variant, demonstrated a marked delay in
endogenous RNF8 degradation kinetics when compared to control
cells (Figs 1H and I, and EV1A–C), suggesting that the rate of RNF8
degradation and its homeostasis are under the control of the p97
system and this effect is not cell type-specific.
As p97 unfolds and extracts predominantly ubiquitinated
proteins from different cellular locations, we next asked if RNF8 is
modified by ubiquitination. HEK293 cells co-transfected with Flag-
RNF8 and HA-Ubiquitin were mock-treated or exposed to IR. The
cells were biochemically fractionated into total soluble (cytosol and
nucleosol) and chromatin pools, and Flag-RNF8 was subsequently
immunopurified under denaturing conditions from both fractions to
analyse its ubiquitination status (Fig EV1D). Ubiquitination of RNF8
was analysed using antibodies recognising either total ubiquitina-
tion (i.e. HA antibody) or specific ubiquitin linkages with a similar
affinity (K48-Ub and K63-Ub; Fig EV1E). RNF8 was strongly ubiqui-
tinated under both physiological and genotoxic conditions, and the
K48-Ub appeared to be the main ubiquitin signal on both soluble
and chromatin-bound RNF8 (Fig EV1D). Furthermore, RNF8 was
hyper-ubiquitinated with K48-Ub in p97-depleted cells when
compared to control cells (Fig 1J), further supporting a role for the
p97 system in processing ubiquitinated RNF8.
To directly prove that RNF8 is a substrate of p97, we performed
co-immunoprecipitation experiments and analysed the physical
association between p97 and RNF8 in vivo. Flag-RNF8 and Strep-
tagged p97 wild type (WT) or p97EQ were mildly co-expressed in
HEK293 cells. The cells were then mock-treated or exposed to IR,
and Strep-tagged p97 complexes were isolated from total cell extract
over streptavidin beads under native and physiological salt
(150 mM NaCl) conditions (Fig 1K and L). The p97-WT isolate
precipitated equal amounts of RNF8 in untreated and IR-treated
conditions. However, the physical association of RNF8 with the
p97EQ variant was increased ~5-fold when compared to p97-WT,
revealing it to be a trapped p97 substrate.
Overall, these data suggest that the p97 ATPase forms a stable
physical complex with the E3 ubiquitin ligase RNF8 under physio-
logical and genotoxic conditions in vivo to prevent RNF8 hyper-
accumulation.
Homeostasis of RNF8 is controlled by auto-ubiquitination and
the ubiquitin–proteasome system
RNF8 is an E3 ubiquitin ligase that, in association with E2-conju-
gating enzymes Ubc13, Ubc8 and Ube2S, forms K63-Ub, K48-Ub or
K11-Ub chains, respectively, on various substrates (Feng & Chen,
2012; Lok et al, 2012; Mallette et al, 2012; Zhang et al, 2013; Thor-
slund et al, 2015; Paul & Wang, 2017). As the K48-Ub is the main
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signal for proteasomal degradation, we asked whether RNF8 is also
able to ubiquitinate itself (auto-ubiquitination) with K48-Ub and
whether this serves as a signal for its own degradation. Flag-RNF8-
WT or Flag-RNF8 bearing one inactivating amino acid mutation
(C403S) in its E3-ligase active centre (RING finger mutated variant,
RING*) (Mailand et al, 2007) was expressed and isolated under dena-
turing conditions. While RNF8-WT was heavily K48-polyubiquiti-
nated and to a much lesser extent K63-polyubiquitinated, the inactive
RNF8-RING* variant was almost completely devoid of ubiquitination
(Fig 2A). Additionally, siRNA-mediated depletion of p97 further
enhanced polyubiquitination of RNF8-WT, but not RNF8-RING*,
suggesting that RNF8 is K48-auto-ubiquitinated and subsequently
processed by p97.
p97 is a central component in the ubiquitin-dependent proteasome
degradation system, but recent data also suggest a role for p97 in the
autophagy-dependent degradation of ubiquitinated substrates (Bug &
Meyer, 2012). To investigate whether RNF8 homeostasis is under
control of the ubiquitin–proteasome system, we monitored the rate of
endogenous RNF8 degradation by cycloheximide (CHX) chase under
physiological conditions (Fig 2B and C, and Appendix Fig S1A and
B). The rate of RNF8 turnover/degradation was analysed in HeLa
cells treated with either DMSO or the proteasome inhibitor MG132.
Endogenous RNF8 degradation was strongly suppressed when the
proteasome was inhibited (Fig 2B and C). Similar to p97-depleted
cells (Fig 1J), inhibition of the proteasome strongly boosted the K48
ubiquitination of RNF8 under physiological conditions (Fig 2D).
Additionally, the degradation kinetics of the Flag-RNF8-WT and Flag-
RNF8-RING* variants were compared in U2OS cells where the
endogenous RNF8 was depleted by RNF8 shRNA (Appendix Fig S1C).
RNF8-WT was rapidly degraded, but the degradation of RNF8-RING*
was completely blocked (Fig 2E and F). Altogether this suggests that
RNF8 generates K48-Ub chains on itself and thus regulates its own
turnover and homeostasis via p97 and the proteasome.
Ataxin 3 is a nuclear p97-associated DUB that interacts
with RNF8
The aforementioned results suggest that RNF8 is heavily auto-
K48-polyubiqiutinated, triggering its degradation by the
p97–proteasome system. This raises the question of how RNF8 is
protected from premature/accelerated degradation. As p97 and the
proteasome co-exist with several DUBs, we reasoned that a DUB
associated with p97 and/or the proteasome might be involved in the
regulation of RNF8 homeostasis.
To test this hypothesis, we performed a SILAC-based quantitative
p97-interactome mass spectrometry. We focused on RNF8 in the
nuclear compartment due to its crucial role in DSB repair. Thus, the
p97-Strep-tag proteome was isolated as previously described (Ritz
et al, 2011) from nuclear fractions of HEK293 cells before and after
exposure to 10 Gy IR (Fig 3A, Table EV1). As expected, p97 inter-
acted with its two main cofactors, the Npl4–Ufd1 complex and p47
and its associated cofactor UBXD7, inside the nucleus. Interestingly,
the p97-associated DUB ATX3 was the only DUB identified in the
nuclear p97 proteome, which mildly increased in association after
IR. The p97 proteome also contained many proteasome subunits,
but not the proteasome-associated DUBs Rpn11/PSMD14, Ubp6/
USP14 or UCH37/UCHL5 (Collins & Goldberg, 2017). We therefore
decided to focus on ATX3.
ATX3 is a member of the polyglutamine repeats (polyQ) disease
family as it contains a polyQ tract at its C-terminal end (Fig 3B). It
is a p97-associated DUB required for cytosolic and endoplasmic
reticulum-associated degradation processes and is capable of cleav-
ing K63-Ub, K48-Ub and mixed Ub chains in vitro (Zhong &
Pittman, 2006; Winborn et al, 2008). ATX3 interacts with p97 via a
VCP-binding motif (VBM), binds ubiquitin via three ubiquitin-
interacting motifs (UIMs) and cleaves ubiquitin chains by a
N-terminal enzymatic region with a catalytic cysteine at position
14 (C14) located in the N-terminal Josephin domain (Burnett et al,
2003). Interestingly, it was recently shown that p97 (CDC-48 in
Caenorhabditis elegans) and ATX3 fine-tune the ubiquitin signal
and regulate apoptotic response to DNA damage in C. elegans
(Ackermann et al, 2016). However, the existence and role of the
p97–ATX3 complex at sites of DNA lesions in vertebrates are not
known. Biochemical fractionation of HEK293 cell extracts and
immunofluorescence (IF) analysis of U2OS cells revealed a sub-
population of ATX3 in the nucleus and on chromatin, further con-
firming our mass spectrometry data that ATX3 is also a nuclear
DUB (Fig EV1F and G).
◀ Figure 1. RNF8 is a ubiquitinated substrate of p97 under physiological and genotoxic conditions.A Western blot analysis showing increased RNF8 protein level in HeLa cells after siRNA-mediated p97 depletion under physiological conditions and after IR (10 Gy).
B Graph represents the quantifications of (A) (***P < 0.001; unpaired t-test, n = 3, mean + SEM).
C Western blot analysis showing increased RNF8 protein level in HeLa cells after p97 chemical inhibition (CB5083, 10 lM for 6 h) under physiological conditions and
after IR (10 Gy).
D Graph represents the quantifications of (C) (**P < 0.01, ***P < 0.001; unpaired t-test, n = 3, mean + SEM).
E Western blot analysis showing increased RNF8 protein level in HEK293 cells after doxycycline-inducible mild expression of the p97EQ variant under physiological
conditions and after IR (10 Gy).
F Graph represents the quantifications of (E) (**P < 0.01, ****P < 0.0001; unpaired t-test, n = 4, mean + SEM).
G Model representing the processing of ubiquitinated substrate by p97 ATPase activity. Inactivation of p97 ATPase activity leads to the accumulation of ubiquitinated
substrate.
H Western blot analysis of CHX chase kinetics showing reduced RNF8 degradation rate in HEK293 cells after siRNA-mediated p97 depletion.
I Graph represents the quantifications of (H) (***P < 0.001, ****P < 0.0001; two-way ANOVA, n = 3, mean + SEM) and Western blot for efficacy of siRNA depletion of
p97 (right).
J Western blot analysis of Flag-RNF8 denaturing-IP in HEK293 cells showing K48-linked hyper-ubiquitination of RNF8 after siRNA-mediated p97 depletion.
K Western blot analysis of Strep-p97 Co-IP in HEK293 cells showing increased RNF8 interaction with p97EQ variant as compared to p97-WT under physiological
conditions and after IR (10 Gy).
L Graph represents the quantifications of (K) (*P < 0.05; unpaired t-test, n = 2, mean + SEM).
Source data are available online for this figure.
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Co-immunoprecipitation experiments with either p97 or ATX3
validated the mass spectrometry findings demonstrating a physical
interaction between p97 and ATX3 in the nucleus (Fig 3C and D).
However, the mildly increased interaction between p97 and ATX3
after IR observed by the SILAC mass spectrometry was not very
clear when analysed by Western blotting. Intriguingly, RNF8 and
the core proteasome subunit alpha 6 (PSa6) were also identified
within the immunoprecipitate under physiological conditions as
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well as post-irradiation (Fig 3D). This suggests the existence of a
p97–ATX3–RNF8–proteasome complex in vivo. In order to test if
p97 and ATX3 cooperate in the processing and homeostasis of
RNF8, we overexpressed Flag-ATX3-WT or Flag-ATX3-VBM* (p97
interaction-deficient variant) and analysed the interaction of these
two ATX3 variants with RNF8 (Fig 3E). ATX3-WT, but not ATX3-
VBM*, formed a physical complex with p97. However, ATX3-VBM*
retained the interaction with RNF8 and the main p97 cofactor
complex Ufd1–Npl4, indicating that p97 cofactors, ATX3 (substrate-
processing cofactor) and Ufd1–Npl4 complex (substrate-recruiting
cofactors) can interact with RNF8 (substrate) independently of p97
(Fig 3E). Interestingly, p97 also binds RNF8 independently of ATX3,
but the interaction between p97 and RNF8 was increased in ATX3-
knockout (ΔATX3) cells (Fig 3F and G). This indicates that ATX3
can counteract the interaction between p97 and RNF8 and that most
probably Ufd1–Npl4 bridges p97 with RNF8, as is the case for many
well-characterised p97 substrates (Buchberger et al, 2015). Overall,
these results suggest that RNF8 forms a complex with the p97
system composed of p97, Npl4–Ufd1 and ATX3 and that p97 and
ATX3 bind RNF8 independently (Fig 3H).
ATX3 DUB activity is strongly reduced in the absence of p97
in vitro (Doss-Pepe et al, 2003; Laco et al, 2012). Likewise, we
observed that the stability of ATX3 at the protein level strictly
depends on p97 in vivo. Depletion of p97 destabilised ATX3 in
HEK293 cells (Appendix Fig S1D). A similar phenotype was
observed when HEK293 or HeLa cells were treated with the allos-
teric p97 inhibitor NMS873, which affects p97 conformation and
thus prevents ATP hydrolysis (Magnaghi et al, 2013; Chou et al,
2014), but not with the p97 ATPase inhibitor DBeQ (Chou et al,
2011) (Appendix Fig S1E and F). We conclude that ATX3 can be
only functional in the context of the p97 system.
ATX3 deubiquitinates RNF8 to protect it from
premature degradation
Since we confirmed an interaction between ATX3 and RNF8 in vivo
(Fig 3), we analysed whether ATX3 regulates RNF8 homeostasis.
First, we observed that the RNF8 protein level was lower for about
20% in ATX3-knockout cells when compared to wild-type cells
(Fig 4A and B). Second, the rate of RNF8 degradation was moni-
tored in ATX3-knockout or siRNA-depleted cells by CHX chase
experiments. In both conditions, RNF8 was rapidly degraded
(Figs 4A and B, and EV2A and B), and this was fully suppressed by
proteasome inhibition (MG132) (Fig 4C). Importantly, ATX3 inacti-
vation did not affect RNF8 transcription (Fig EV2C). This strongly
supports the idea that ATX3 is the DUB that counteracts RNF8 auto-
ubiquitination and thus p97-facilitated degradation.
To further investigate how ATX3 affects RNF8 ubiquitination, we
immunopurified Flag-RNF8 under denaturing conditions from cell
extracts where either p97 or ATX3 was depleted (Fig 4D). Depletion
of either p97 or ATX3 strongly enhanced RNF8 polyubiquitination,
suggesting that the processing of ubiquitinated RNF8 is modulated
by both p97 and ATX3. To directly prove that ATX3 deubiquitinates
RNF8, we co-expressed Flag-RNF8 in either HeLa-WT or ATX3-
knockout cells together with GFP-ATX3-WT, catalytically inactive
GFP-ATX3-C14A or ubiquitin-binding-defective interacting motifs
(UIMs*) GFP-ATX3-UIM* variants. RNF8 was immunoprecipitated
under denaturing conditions, and the polyubiquitination pattern on
RNF8 was analysed (Fig 4E). RNF8 displayed increased polyubiqui-
tination in ATX3-knockout cells in comparison with WT cells
(Fig 4E). These ubiquitin chains were mostly removed when ATX3-
WT but not ATX3-C14A or ATX3-UIM* was expressed (Fig 4E;
compare lanes 5, 6 and 7). The linkage type of the polyubiquitina-
tion was confirmed with K48-Ub chain-specific antibody.
In line with the above findings, accelerated RNF8 degradation
was observed in ATX3-C14A- or ATX3-UIM*-expressing cells as
compared to ATX3-WT (Fig 5A–D). This accelerated degradation of
RNF8 was rescued significantly by reintroducing ATX3-WT but not
the ATX3-VBM variant (Fig 5E and F). Interestingly, inactivation of
either ATX3 or RNF8 without any genotoxic stress caused increased
level of micronuclei formation (Fig 5G and H).
Altogether, these data show that ATX3, via its deubiquitinating
activity (C14) and ubiquitin-binding capacity (UIMs), regulates
RNF8 stability by removing its associated K48-polyubiquitin chains
from (i) RNF8 in close association with p97 (VBM), and (ii) both
proteins, ATX3 and RNF8, are essential for maintenance of genomic
stability under physiological conditions.
The p97–ATX3–RNF8 axis is essential for cell survival after
IR-induced genotoxic stress
Our findings that p97 and ATX3 regulate RNF8 homeostasis under
physiological conditions led us to speculate that this could be of
importance when DNA damage occurs in cells as RNF8 is critical for
accurate DSB repair and cell survival.
We performed neutral DNA comet assays to directly quantify
amounts of genomic DSBs (Fig 6A; Nickson et al, 2017; Carter et al,
2018). Depletion of ATX3 with two different siRNAs significantly
increased the level of DSBs even in unchallenged conditions. This
result together with the increased levels of micronuclei in
◀ Figure 2. Homeostasis of RNF8 is controlled by auto-ubiquitination and the ubiquitin–proteasome system.A Western blot analysis of Flag-RNF8 denaturing-IP in HEK293 cells showing the ubiquitination pattern of RNF8-WT and RNF8-RING* variant, under siRNA-mediated
luciferase (siLuc) or p97-depleted conditions (sip97).
B Western blot analysis of CHX chase kinetics in HeLa cells showing the degradation kinetics of RNF8 and inhibition of RNF8 degradation by simultaneous proteasome
inhibition (MG132, 10 lM).
C Graph represents the quantifications of (B) (ns: not significant, P > 0.05, ****P < 0.0001; two-way ANOVA, n = 2, mean + SEM).
D Western blot analysis of Flag-RNF8 denaturing-IP in HEK293 cells showing hyper-ubiquitination of RNF8 after proteasome inhibition (MG132, 10 lM for 6 h).
E Western blot analysis of CHX chase kinetics in U2OS cells, comparing the degradation rate of Flag-RNF8-WT and Flag-RNF8-RING*. Endogenous RNF8 was depleted
by shRNF8 targeting only endogenous RNF8.
F Graph represents the quantifications of (E) (nsP > 0.05, ****P < 0.0001; two-way ANOVA, n = 3, mean + SEM).
Source data are available online for this figure.
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Figure 3. Ataxin 3 is a nuclear p97 associated DUB that interacts with RNF8.
A Schematic representation of a SILAC-based mass spectrometry approach (upper graph). The p97 interactome showing ATX3 as the only DUB in nucleus with increased
interaction with p97 after IR (10 Gy; lower graph).
B Schematic representation of ATX3 domain structure. C14: cysteine catalytic centre at amino acid 14; UBS1 or 2: ubiquitin-binding site 1 or 2; UIM: ubiquitin-
interacting motif; VBM: p97 binding motif; polyQ: polyglutamine region.
C Western blot analysis of Strep-p97 Co-IP in nuclear fraction of HEK293 cells showing interaction of p97 with ATX3 under physiological conditions and after IR (10 Gy).
D Western blot analysis of Flag-ATX3 Co-IP in HEK293 cells showing interaction of ATX3 with p97, RNF8 and PSa6 under physiological conditions and after IR (10 Gy).
E Western blot analysis of Flag-ATX3 WT or Flag-ATX3 VBM* Co-IP in HEK293 cells showing interaction of ATX3 with p97, RNF8 and p97 core cofactors Npl4–Ufd1
(* represents unspecific bands).
F Western blot analysis of Strep-p97EQ Co-IP in HEK293 cells, in the presence or absence (CRISPR knockout; ΔATX3) of ATX3, showing increased interaction of RNF8
with p97 in the absence of ATX3, under physiological conditions and after IR (10 Gy).
G Graph represents quantifications of (F) (*P < 0.05, **P < 0.01; unpaired t-test, n = 3, mean + SEM).
H Model showing the interaction of p97 and ATX3 with ubiquitinated RNF8.
Source data are available online for this figure.
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Figure 4. ATX3 deubiquitinates RNF8.
A Western blot analysis of CHX chase kinetics in HeLa cells showing accelerated endogenous RNF8 degradation in the soluble fraction (cytosol and nucleosol) of ΔATX3
cell extract. Arrow represents the main RNF8 band, and asterisks represent unspecific bands.
B Graphs represent the quantifications of (A). RNF8 level at starting point (0 h) was shown without equalisation (left). In order to nullify the difference in RNF8 level at
starting point (0 h), we equalised RNF8 level to 100% and then compared the degradation rate (right) (**P < 0.01, ***P < 0.001, ****P < 0.0001; two-way ANOVA,
n = 2, mean + SEM).
C Western blot analysis of CHX chase showing the kinetics of endogenous RNF8 degradation in the soluble fraction (cytosol and nucleosol) of ATX3-knockdown HeLa
cells. The degradation was completely blocked after simultaneous inhibition of proteasome (MG132, 10 lM).
D Western blot analysis of Flag-RNF8 denaturing-IP in HEK293 cells showing RNF8 hyper-ubiquitination in siRNA-mediated p97 or ATX3-depleted conditions.
E Western blot analysis of Flag-RNF8 denaturing-IP in HeLa cells showing RNF8 hyper-ubiquitination in ΔATX3 condition. RNF8 hyper-ubiquitination was suppressed
by reintroduction of GFP-ATX3-WT but not with GFP-ATX3-C14A or GFP-ATX3-UIM*.
Source data are available online for this figure.
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unchallenged ATX3- or RNF8-depleted U2OS cells further demon-
strated the essential role of ATX3 and RNF8 in ensuring genome stabil-
ity under physiological conditions. Moreover, the repair of IR-induced
DSBs was also strongly impeded in ATX3-inactivated cells (Fig 6A).
We next monitored cell survival after IR treatment in either p97-
or ATX3-depleted HeLa cells. As previously shown (Meerang et al,
2011), depletion of p97 hyper-sensitised cells to IR. ATX3-depleted
cells were also hypersensitive to IR, to a similar extent as p97-
depleted cells (Fig 6B). The role of ATX3 in protecting cells from IR
was further confirmed in ATX3-knockout cells (Fig 6C). Impor-
tantly, the cellular hypersensitivity to IR in the absence of ATX3
was rescued to the level of control cells when ATX3-WT but not
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ATX3-C14A, ATX3-UIM* (Fig 6D) or ATX3-VBM (Fig 6E) variants
were expressed. This suggests that enzymatic processing of ubiquiti-
nated substrates by ATX3 is critical for DSB repair and cell survival
after IR treatment and that this role of ATX3 is strictly p97-depen-
dent.
The p97–ATX3 complex suppresses overaccumulation of RNF8
and K63-Ub at sites of DNA damage
To elucidate mechanistic insight of the p97–ATX3–RNF8 complex in
DSB repair, we focused on sites of DNA lesions induced by either IR
or UV-laser micro-irradiation. Both approaches cause DSB formation
where RNF8-dependent ubiquitination is vital for orchestration of
the DDR and consequently repair and cell survival (Kolas et al,
2007; Mailand et al, 2007; Feng & Chen, 2012).
As p97 and ATX3 also relocate quickly to sites of DNA damage
(Fig EV2D), we asked whether the p97–ATX3 complex regulates
RNF8 association with DSB sites. We therefore monitored RNF8
levels, and the ubiquitin signal as a read-out of RNF8 activity, after
DNA damage induction in U2OS cells. Similar to the findings with
the soluble pool of RNF8, depletion (Appendix Fig S1G) or chemical
inhibition (CB5083) of p97 caused hyper-accumulation of RNF8
(Figs 6F and G, and EV2E–G) and K63-Ub (Fig 6I and J) at the sites
of DNA damage at both time points analysed. Surprisingly, depletion
of ATX3 with three different siRNAs also caused RNF8 and K63-Ub
hyper-accumulation although to a lesser extent than in p97-depleted
cells. The specificity of the antibody for endogenous RNF8 was con-
firmed by siRNA-mediated RNF8 depletion (Appendix Fig S1H).
While this manuscript was in preparation, it was reported that
siRNA-mediated ATX3 depletion attenuates RNF8 recruitment and
K63-Ub formation at sites of DNA damage (Pfeiffer et al, 2017). To
address this, we have investigated RNF8 protein levels at the sites of
DNA lesions by using three different sources of DNA damage: IR
(Fig 6F–H), UV-laser micro-irradiation (Fig EV2E–G) and two-
photon laser micro-irradiation (Fig EV2K and L), and two different
antibodies against endogenous RNF8 (Fig EV2E–G and H); and we
also analysed the behaviour of constitutively expressed GFP-RNF8
in fixed or living cells (Figs 6F and G, and EV2K and L). Our cumu-
lative observations all support that RNF8 protein accumulates at
sites of DNA damage under ATX3-deficient conditions. We also
analysed the recruitment of endogenous and ectopically expressed
Flag-RNF8 at the sites of UV-induced DNA damage in ATX3-
depleted U2OS cells (Fig EV2E–G, I and J) as well as in ATX3-
knockout HeLa cells (Appendix Fig S1I and J). Both RNF8 versions,
endogenous and ectopically expressed, also hyper-accumulated at
the sites of DNA damage in ATX3-knockout HeLa cells. In addition,
RNF8 also increased its accumulation on total chromatin fraction in
ATX3-inactivated cells and was modified, most probably by ubiqui-
tination (Appendix Fig S1K and L). Interestingly, inactivation of the
known p97 cofactor complex for DSB repair, the Ufd1–Npl4 hetero-
dimer (Meerang et al, 2011; van den Boom et al, 2016), by siRNA-
mediated Npl4 depletion did not cause RNF8 hyper-accumulation at
sites of IR-induced DNA lesion in fixed cells (Fig EV2M and N).
Furthermore, the inactivation of Ufd1-Npl4 complex, by either
siRNA-mediated Npl4 or Ufd1 depletion, also did not cause any
RNF8 hyper-accumulation at the sites of two-photon micro-irradia-
tion damage in living cells (Fig EV2K). However, inactivation of p97
by chemical inhibition or siRNA-mediated ATX3 depletion again
strongly induced RNF8 accumulation at the sites of IR or two-
photon micro-irradiation DNA lesions in fixed or living cells, respec-
tively (Fig EV2K and L). This suggests the existence of a p97–ATX3
complex, which, independently of the known Ufd1-Npl4 core cofac-
tor complex for DSB repair, extracts RNF8 from the sites of DNA
damage.
These results also raised the question of whether MDC1, as the
platform for RNF8 recruitment to sites of DSB, is one of the most
relevant ATX3 substrates in DSB repair as reported (Pfeiffer et al,
2017). Thus, we tested whether MDC1 is present in the ATX3
complex under physiological or IR-induced conditions (Fig EV3A).
Despite endogenous MDC1 being strongly visible in the input frac-
tion, MDC1 signal was not detectable in GFP-ATX3 co-immunopreci-
pitate under our experimental conditions. In contrast, endogenous
RNF8 or even KU70 co-precipitated with ectopically expressed ATX3
(Figs EV3A, and 3D and E).
Analysis of IR-induced MDC1 foci formation and resolution at the
sites of DNA damage (c-H2AX) (Fig EV3B and C) and MDC1 phos-
phorylation status (Fig EV3D) indicated that ATX3-knockout cells
have a functional MDC1 response after IR. Moreover, ATX3-knockout
◀ Figure 5. ATX3 protects RNF8 from premature degradation.A Western blot analysis of CHX chase showing accelerated degradation of RNF8 in soluble fraction (cytoplasm + nucleoplasm) of HeLa cells, expressing DOX-inducible
GFP-ATX3-C14A variant as compared to GFP-ATX3-WT. Endogenous ATX3 was depleted with siRNA targeting 30UTR region of ATXN3.
B Graph represents the quantifications of (A). In order to nullify the difference in RNF8 level at starting point (0 h), we equalised RNF8 level to 100% and then
compared the degradation rate. RNF8 level at starting point (0 h) was also shown without equalisation (*P < 0.05, **P < 0.01; two-way ANOVA, n = 2, mean + SEM).
C Western blot analysis of CHX chase showing accelerated degradation of RNF8 in soluble fraction (cytoplasm + nucleoplasm) of HeLa cells, expressing DOX-inducible
ATX3-UIM* variant as compared to ATX3-WT. Endogenous ATX3 was depleted with siRNA ATX3_30UTR.
D Graph represents the quantifications of (C). In order to nullify the difference in RNF8 level at starting point (0 h), we equalised RNF8 level to 100% and then
compared the degradation rate. RNF8 level at starting point (0 h) was also shown without equalisation (nsP > 0.05, *P < 0.05, **P < 0.01, ****P < 0.0001; two-way
ANOVA, n = 2, mean + SEM).
E Western blot analysis showing endogenous RNF8 protein level in soluble fraction (cytosol and nucleosol) of HeLa cells under indicated conditions. RNF8 level was
significantly reduced after siRNA-mediated ATX3 depletion and then was significantly rescued by DOX-inducible expression of GFP-ATX3-WT but not with GFP-ATX3-
VBM.
F Graphs represent the quantifications of (E) (nsP > 0.05, *P < 0.05, **P < 0.01; unpaired t-test, n = 3, mean + SEM).
G Representative IF images showing c-H2AX-positive micronuclei (white arrows) under physiological conditions with indicated siRNA-mediated depletion. Scale bar:
10 lm.
H Graph represents quantification of (G), showing percentage of cells with c-H2AX-positive micronuclei in U2OS cells (*P < 0.05, **P < 0.01, ***P < 0.001; unpaired
t-test, n = 3, mean + SEM, at least 200 randomly selected nuclei were counted per condition per experiment).
Source data are available online for this figure.
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cells displayed delayed clearance of both MDC1 and c-H2AX from
DSB sites, suggesting defective DSB repair.
Overall, we concluded that ATX3 inactivation causes retention
and consequently increased accumulation of RNF8 at DSB sites.
Increased accumulation of RNF8 in p97 or ATX3-inactivated cells
was directly responsible for the increased accumulation of K63-Ub
at damage sites, as co-depletion of RNF8 completely suppressed this
phenotype (Fig EV3E and F). Additionally, RNF8 auto-ubiquitina-
tion was directly responsible for the removal of RNF8 from sites of
DNA damage, as expression of RNF8-RING* caused strong retention
and hyper-accumulation of RNF8-RING* at the sites of DNA damage
at either time point (Fig EV3G and H). This finding was also con-
firmed at sites of DSBs induced by IR in U2OS cells (Fig 6F and H).
Short inhibition of proteasome activity with MG132 causes deple-
tion of the nuclear ubiquitin pool (Dantuma et al, 2006). MG132
treatment led to the accumulation of RNF8 (Appendix Fig S1M and
N), which further supports that the turnover of RNF8 from sites of
DNA damage is a ubiquitin-dependent process. Strikingly, depletion
of p97 increased the accumulation of both K48-Ub (Fig EV4A and B)
and K63-Ub (Fig 6I and J) at sites of DNA damage (Baranes-Bachar
et al, 2018), indicating that several different substrates of p97 are
accumulating in its absence. However, inactivation of ATX3 only
increased the accumulation of K63-Ub at sites of DNA damage. This
corresponds to the increased amount of RNF8 at sites of DNA lesion
and suggests that RNF8 remains enzymatically active. Therefore,
the p97–ATX3 complex selectively extracts a subset of p97
substrates from DNA lesions.
Overall, our data demonstrate that the p97–ATX3 complex
prevents excessive accumulation of RNF8 at sites of DNA damage,
and this removal depends on RNF8 E3-ligase activity and the protea-
some.
The p97–ATX3 complex fine-tunes histone H1 ubiquitination
after DSBs
In contrast to RNF8 accumulation at DSB sites, recruitment of the
downstream factors RNF168 and 53BP1 was reduced at the early
time point (30 min) post-UV-laser irradiation (Fig 7A–D) in both
p97- or ATX3-depleted cells. Similar results were obtained for 53BP1
when DSBs were induced by IR in GFP-RNF8-expressing cells
(Fig 6F and G). This suggests that unrestrained K63 ubiquitination
at DSB sites due to p97–ATX3 inactivation may be leading to
dysfunctional DSB repair.
The essential signals for RNF168 recruitment are the K63-
ubiquitin chains on histone H1 generated by RNF8 (Thorslund et al,
2015). We therefore monitored the status of histone H1 ubiquitina-
tion in either p97- or ATX3-depleted cells by biochemical isolation
of histone H1 under denaturing conditions. Surprisingly, similar to
RNF8 knockdown and consistent with defective RNF168 recruit-
ment, histone H1 ubiquitination was strongly impaired in both p97-
and ATX3-depleted cells at the early 30-min time point after IR
(Fig 7E). However, at the late time point (5 h), histone H1 ubiquiti-
nation was restored to the levels observed in control cells in both
p97- and ATX3-depleted cells (Fig EV4C and D) correlating with the
increased recruitment observed for RNF168 and 53BP1 to sites of
DNA damage in ATX3-depleted cells at the 5-h time point (Fig 7A–
D, 5-h time point). The recruitment of RNF168 and 53BP1 was not
rescued in the case of p97 depletion, indicating pleiotropic effects of
p97 at the site of DSBs.
Overall, this shows that the p97–ATX3 complex extracts RNF8
from sites of DNA damage to facilitate the timely ubiquitination of
H1 and recruitment of downstream factors RNF168/53BP1.
p97–ATX3-mediated RNF8 homeostasis at sites of DNA damage
orchestrates DSB repair pathway choice
In contrast to the defective recruitment of RNF168 and 53BP1
(Fig 7A–D), the recruitment of BRCA1 to either UV-micro-irradiated
lesions (Fig 7F and G) or IR-induced foci (Fig EV4E–G) was not
affected in ATX3-depleted conditions. Similar results were obtained
for the BRCA1 ubiquitin-binding partner RAP80 (Fig EV5A and B).
Unlike ATX3 inactivation where only one branch of DSB repair
pathway signalling was affected (RNF168/53BP1 for NHEJ), inacti-
vation of p97 impaired the recruitment of the key factors in both
DSB repair pathways: BRCA1 and Rad51 (HR pathway) and 53BP1
(NHEJ pathway) (Figs 7A–F, and EV4E–G, and EV5C and D). These
results suggest that there are several p97 complexes or even sub-
complexes working at the sites of DSB lesions, and inactivation of
◀ Figure 6. The p97–ATX3 complex suppresses hyper-accumulation of RNF8 and K63-Ub at sites of DNA damage.A Quantifications of neutral comet assay showing the level of DSBs under indicated siRNA-depleted conditions, before and after IR (4 Gy) (*P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001; two-way ANOVA, n = 3, mean + SEM).
B Colony formation assay (CFA) showing the IR sensitivity of HeLa cells under siRNA-mediated p97 or ATX3-depleted conditions (n = 3, mean  SD).
C CFA showing the IR sensitivity of HeLa-WT cells compared to HeLaΔATX3 cells (n = 3, mean  SD).
D CFA showing the rescue of cell survival in IR-treated, ATX3-depleted (siRNA), HeLa cells, after DOX-inducible expression of ATX3-WT but not with ATX3-C14A or ATX3-
UIM* variant (nsP > 0.05, **P < 0.01, ****P < 0.0001; two-way ANOVA, n = 3, mean  SD).
E CFA showing the rescue of cell survival in IR-treated, ATX3-depleted (siRNA), HeLa cells, after DOX-inducible expression of ATX3-WT but not with ATX3-VBM variant
(nsP > 0.05, *P < 0.05, ***P < 0.001, ****P < 0.0001; two-way ANOVA, n = 3, mean  SD).
F Representative IF micrographs in U2OS cells showing IRIF formation of GFP-RNF8-WT, 53BP1 and c-H2AX (first panel) and GFP-RNF8-ΔRING, 53BP1 and c-H2AX
(second panel) under indicated siRNA-depleted or p97-inhibited (CB5083) conditions. Scale bar: 10 lm.
G Quantification of (F) for GFP-RNF8-WT. Graph represents the percentage of cells with increased GFP-RNF8-WT foci (white bars) or percentage of cells with > 5 53BP1
foci (grey bars) (***P < 0.001, ****P < 0.0001; two-way ANOVA, n = 2, mean + SEM, at least 100 nuclei per condition and experiment).
H Quantification of (F) for GFP-RNF8-ΔRING. Graph represents the percentage of cells with increased GFP-RNF8-ΔRING foci (white bars) or percentage of cells with > 5
53BP1 foci (grey bars) (nsP > 0.05, *P < 0.01, **P < 0.01, ****P < 0.0001; two-way ANOVA, n = 2, mean + SEM, at least 100 nuclei per condition and experiment).
I Representative IF images and quantification showing endogenous K63-Ub and c-H2AX at UV-A micro-laser-induced DNA damage tracks in U2OS cells under indicated
siRNA-depleted conditions. Scale bar: 10 lm.
J Quantification of (I). Graph represents the average intensity of the K63-Ub (nsP > 0.05, **P < 0.01, ***P < 0.001; unpaired t-test, n = 2, mean + SEM, more than 50
nuclei were analysed).
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p97 as their main conductor inactivates all of these complexes/sub-
complexes and causes pleiotropic effects. The p97–ATX3 complex
facilitates RNF8 turnover at DSB sites and thus positively and specif-
ically influences the timely ubiquitination of histone H1 and recruit-
ment of RNF168 and 53BP1 and, accordingly, promotes the NHEJ
repair pathway.
To further investigate how ATX3 balances DSB pathway choice,
we analysed the cell cycle profile in HEK293 and U2OS cells. ATX3-
knockout or ATX3 siRNA-depleted cells caused a slight increase of
cells in G1 phase and decreased cells in the S/G2 phase when
compared to wild-type cells (Appendix Fig S2A–G). This is likely
due to increased genomic instability in ATX3-inactivated cells.
Despite this, the level of 50-DNA end resection in S-phase positive
cells, measured by either Rad51 or phospho-RPA foci formation,
was significantly increased in ATX3-inactivated cells (Fig EV5E and
F). This additionally suggests that ATX3 inactivation does not affect
initial steps of the HR pathway, namely 50-DNA end resection.
We concluded that the increased level of 50-DNA end resection in
ATX3-inactivated cells is a consequence of elevated amount of
RNF8 at DSB sites and formation of the K63-Ub that is still able to
recruit the RAP80-BRCA1 complex (Figs 7F, G, and EV4E–G, and
EV5A, B). However, increased levels of enzymatically functional
RNF8 at sites of DNA damage negatively influence timely ubiquiti-
nation of histone H1 and consequent recruitment of RNF168/53BP1
and execution of the NHEJ pathway.
To investigate this hypothesis, we used GFP-reporter assays to
measure the efficiency of each repair pathway (Bennardo et al,
2008). Depletion of p97 markedly affected both DSB repair pathways
(Fig 8A and B). However, depletion of ATX3 specifically affected the
efficiency of NHEJ but not HR. To further validate these findings, we
took advantage of isogenic human cell lines where either 53BP1
(MCF7) or BRCA2 (DLD1) was knocked out (Fig 8C and D). Cells
were exposed to IR in the presence or absence of independent siRNAs
against ATX3, and cell survival was monitored by colony formation
assay. Depletion of ATX3 did not further sensitise 53BP1-knockout
(NHEJ-deficient) cells to IR (Fig 8C), suggesting that ATX3 and
53BP1 are epistatic. However, depletion of ATX3 in BRCA2-knockout
(HR-deficient) cells further radio-sensitised these cells causing
synthetic lethality (Fig 8D), indicating that ATX3 and BRCA2 func-
tion in two distinct pathways for cell survival after IR. Altogether,
these results further support our findings that ATX3 selectively fine-
tunes DSB repair by preventing extensive RNF8/K63-ubiquitin
signalling, which balances DSB repair pathway choice.
Finally, if this model is correct, then removal of RNF8 in ATX3-
depleted cells should prevent excessive 50-DNA end resection and
restore cell survival after IR. As expected, depletion of ATX3 caused
increased Rad51 recruitment to DSBs and hypersensitivity to IR
(Fig 8E–G). Importantly, co-depletion of ATX3 and RNF8
suppressed both excessive Rad51 recruitment and hypersensitivity
of cells to IR (Fig 8E–G). These data and previous results demon-
strate that (i) ATX3 directly regulates RNF8, (ii) ATX3 counteracts
excessive RNF8-dependent 50-DNA end resection to support the
RNF168/53BP1/NHEJ pathway and (iii) ATX3 and RNF8 are antago-
nistic in terms of cell survival to IR.
Discussion
Here, we discovered a mechanism that regulates the homeostasis of
the E3 ubiquitin ligase RNF8 under physiological and genotoxic
conditions (Fig 8H). We demonstrated that the ubiquitin-dependent
machinery, composed of the ATPase p97 unfoldase/segregase and
the DUB ATX3, regulates RNF8 turnover in a proteasome-dependent
manner. Our results reveal a mechanism to explain how the p97–
ATX3–RNF8 complex fine-tunes DSB repair by preventing excessive
RNF8-dependent K63-Ub modifications and 50-DNA end resection
and consequently promoting the NHEJ pathway, an essential path-
way for cell survival after IR and thus cancer cell resistance to radio-
therapy (Jeggo et al, 2011; Jeggo & Lobrich, 2015). As both p97 and
ATX3 are druggable enzymes (Chou et al, 2014) and p97 inhibitors
are in clinical trials for the treatment of several cancer types (Zhou
et al, 2015), our findings pave the way for using p97 and ATX3 inhi-
bitors as potential radiosensitisers clinically. In addition, as many
cancers have dysregulated DNA repair pathways, inactivation of the
p97–ATX3 complex might be a promising strategy to induce
synthetic lethality in those cancers where the HR pathway is inacti-
vated, such as BRCA2-deficient cancers. Indeed, inactivation of
ATX3 caused synthetic lethality in BRCA2-knockout but not in
53BP1-knockout cells, further supporting our findings that the p97–
ATX3 complex positively stimulates NHEJ (53BP1-dependent) by
suppressing excessive 50-DNA end resection, an initial step of the
HR (BRCA-dependent) repair pathway.
Regulation of RNF8 during physiological and
genotoxic conditions
Our biochemical and cell biology data acquired in several human
cell lines suggest two modes of RNF8 homeostasis and regulation
(Fig 8H; Model).
Mode I: The p97–ATX3 sub-complex preserves a soluble pool of
RNF8. Soluble RNF8 is constantly K48-auto-ubiquitinated by its own
E3-ligase activity, and this signals for p97-dependent proteasomal
◀ Figure 7. The p97–ATX3 complex fine-tunes histone H1 ubiquitination after DSBs.A Representative IF images showing the average intensity of endogenous RNF168 at UV-A micro-laser-induced DNA damage tracks in U2OS cells. Scale bar: 10 lm.
B Graph represents the quantification of (A) (***P < 0.001; unpaired t-test, n = 3, mean + SEM, more than 50 nuclei were analysed).
C Representative IF images showing the average intensity of endogenous 53BP1 at UV-A micro-laser-induced DNA damage tracks in U2OS cells. Scale bar: 10 lm.
D Graph represents the quantification of (C) (nsP > 0.05, ***P < 0.001; unpaired t-test, n = 2, mean + SEM, at least 80 nuclei per condition and experiment).
E Western blot analysis of Flag-histone H1 denaturing-IP, showing ubiquitination pattern of histone H1 after 30 min of IR (10 Gy) treatment under indicated siRNA-
depleted conditions.
F Representative IF images showing the average intensity of endogenous BRCA1 at UV-A micro-laser-induced DNA damage tracks in U2OS cells. Scale bar: 10 lm.
G Graph represents the quantification of (F) (nsP > 0.05, ***P < 0.001; unpaired t-test, n = 2, mean + SEM, at least 100 nuclei per condition and experiment).
Source data are available online for this figure.
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degradation. This pathway is counteracted by ATX3, which removes
K48-Ub from RNF8 and thus slows down the rate of RNF8 degrada-
tion. Our results suggest that p97, ATX3 and RNF8 form a constitu-
tive physical and functional complex, which is essential to maintain
physiological expression levels of RNF8.
Mode II: In response to genotoxic stress, the p97–ATX3 sub-complex
works synergistically to prevent increased accumulation of RNF8 at
sites of DNA lesions by physical extraction of RNF8 from chromatin.
High level of RNF8/K63-Ub at the sites of DNA lesions in p97–
ATX3-inactivated cells correlates with delayed recruitment of down-
stream molecules including RNF168 and 53BP1 that are essential to
facilitate NHEJ-mediated DSB repair. In this scenario, ATX3
promotes sufficient p97-dependent extraction of RNF8 in a classical
ERAD-like manner (Wang et al, 2006; Zhong & Pittman, 2006).
These findings are in line with the fact that p97 must associate with
a DUB to process polyubiquitinated substrates (Bodnar & Rapoport,
2017a,b). The role of p97 in chromatin-associated degradation and
consequently in DNA replication and repair was always linked to its
main cofactor complex Ufd1–Npl4. In our experimental settings,
inactivation of the Ufd1–Npl4 complex did not cause significant
RNF8 hyper-accumulation at the sites of DNA lesion. This suggests
that the p97–ATX3 complex is capable of promoting RNF8 chro-
matin extraction from the sites of DNA damage independently of its
major cofactor involved in DSB repair, the Ufd1–Npl4 heterodimer.
Altogether, this suggests the existence of distinct p97 complexes or
even sub-complexes on chromatin and at sites of DNA damage,
which process different substrates in a tightly controlled manner.
This conclusion is additionally supported by results presented here
that p97 inactivation causes increased accumulation of both K48-Ub
and K63-Ub at the sites DNA lesions, yet ATX3 inactivation only
affects K63-Ub. Further studies will be needed to address if addi-
tional cofactors are involved in the p97–ATX3 complex for process-
ing of RNF8 at sites of DNA damage.
Importantly, our findings on the differential roles of ATX3 on
chromatin-associated RNF8 (extraction) and soluble RNF8 (preven-
tion of premature degradation) parallel previous studies on p97 and
ATX3 in regulating the ER-associated T-cell receptors and p97–ATX3
substrates, CD3d and TCRa (Zhong & Pittman, 2006). There, similar
to our observation with RNF8, ATX3 was shown to regulate the
level of ER soluble substrates (CD3d and TCRa) by slowing down
their premature degradation, but at the same time, ATX3 assists p97
in CD3d and TCRa extraction from the ER.
Taken together, our data suggest that ATX3 constantly regulates
p97-dependent substrate processing, but the final fate of the
substrates depends on their cellular localisation. When substrates
are soluble, ATX3 prevents their premature degradation by remov-
ing K48-linked Ub chains to slow down the rate of p97-dependent
degradation. When substrates are either embedded in the ER or
bound to chromatin, then the p97 ATPase first needs to extract them
from these compartments. Here, ATX3 assists the p97-dependent
substrate extraction of the substrates from the ER or chromatin by
trimming their associated ubiquitin chains to allow timely process-
ing of the substrates (extraction from ER or chromatin), most proba-
bly through the central pore of p97 in a manner recently described
(Bodnar & Rapoport, 2017b). The different roles of ATX3 on RNF8
could be potentially regulated by two different ubiquitin chain types
on RNF8 (K48 and K63; Fig EV1D) and/or the phosphorylation
status of ATX3 (Matos et al, 2016), as recently described for the
DUB OTUD4 (Zhao et al, 2018). Unphosphorylated OTUD4 trims
K48-Ub signals from alkylation DNA repair proteins and thus coun-
teracts their proteasomal degradation. However, when phosphory-
lated, OTUD4 becomes a K63-Ub-specific protease that inhibits the
K63-Ub-dependent inflammatory signalling pathway.
The p97–ATX3 complex promotes NHEJ repair pathway
p97 is physically recruited to sites of DSBs, and its recruitment
partially depends on DNA-PK phosphorylation or RNF8 and RNF168
ubiquitination (Livingstone et al, 2005; Acs et al, 2011; Meerang
et al, 2011). This suggests that p97 is recruited to sites of DNA
damage at multiple levels to remodel and extract various ubiquiti-
nated substrates (Acs et al, 2011; Meerang et al, 2011; Ramadan,
2012; Puumalainen et al, 2014). p97 extracts the polycomb protein
L3MBTL1, the KU70/80 heterodimer and Rad51, suggesting a multi-
faceted role of p97 in DSB repair (Acs et al, 2011; Bergink et al,
2013; van den Boom et al, 2016). It was recently demonstrated that
p97 together with its major cofactor complex Ufd1–Npl4 strictly
regulates the HR repair pathway by removing KU70/80 from DSBs
to allow 50-DNA end resection, Rad51 loading and HR repair activa-
tion (van den Boom et al, 2016). Moreover, van den Boom et al
◀ Figure 8. The p97–ATX3 complex promotes accurate execution of NHEJ and DSB repair.A GFP based reporter assay showing the efficiency of NHEJ repair pathway under indicated siRNA-depleted conditions in HEK293 cells. Graph represents the
quantifications from three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA, n = 3, mean + SEM).
B GFP based reporter assay showing the efficiency of HR repair pathway under indicated siRNA-depleted conditions in HEK293 cells. Graph represents the
quantifications from three independent experiments (nsP > 0.05, **P < 0.01; one-way ANOVA, n = 3, mean + SEM).
C CFA showing the IR sensitivity of 53BP1-proficient and 53BP1-deficient MCF7 cells under indicated siRNA-depleted conditions. Data were collected from two
individual experiments with triplicates (nsP > 0.05; two-way ANOVA, n = 2, mean  SEM).
D CFA showing the IR sensitivity of BRCA2-proficient and BRCA2-deficient DLD1 cells under indicated siRNA-depleted conditions. Data were collected from two
individual experiments with triplicates (**P < 0.01, ***P < 0.001; two-way ANOVA, n = 2, mean  SEM).
E Representative IF images showing Rad51 foci in S-phase (EdU-positive) U2OS nucleus after 5 h of IR (2 Gy) exposure. Scale bar: 10 lm.
F Graph represents the quantification of (E) showing average number of Rad51 foci per S-phase (EdU-positive) nucleus (nsP > 0.05, ****P < 0.0001; unpaired t-test,
n = 2, mean + SEM, at least 50 nuclei per condition and experiment).
G CFA showing the rescue of cell survival in IR-treated, ATX3-depleted (siRNA), HeLa cells, after co-depletion (siRNA) of RNF8 (nsP > 0.05, *P < 0.05, ***P < 0.001;
two-way ANOVA, n = 3, mean  SEM).
H Model of the p97–ATX3 complex in the regulation of RNF8 homeostasis under physiological condition (soluble environment) and in RNF8 chromatin extraction at
sites of DSBs to promote NHEJ.
Source data are available online for this figure.
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demonstrated that chemical inhibition of p97 does not affect DSB
repair after IR, which is in line with their model that p97 inactiva-
tion causes KU70/80 retention and presumably enhanced repair by
the NHEJ pathway, a major pathway for IR-induced DNA damage
repair (Jeggo et al, 2011). In addition, they suggested that p97
favours error-free HR over error-prone NHEJ. However, we here
demonstrate that p97 inactivation affects both major DSB repair
pathways (HR and NHEJ), and we identified a p97 complex, p97–
ATX3, which stimulates the NHEJ repair pathway, by preventing
excessive RNF8/K63-Ub accumulation that promotes 50-DNA end
resection and thus the HR pathway.
Even though it is often considered that RNF8 and RNF168 sit in
the same signalling cascade, work from several laboratories demon-
strated a clear separation between RNF8 and RNF168 function in
DSB repair (Stewart et al, 2007; Hodge et al, 2016). For example,
complementation of RNF8-knockout MEFs with RNF8 restores the
recruitment of the downstream repair/signalling molecules (BRCA1
and 53BP1) important for both HR and NHEJ repair pathways.
However, complementation of RNF8-knockout MEFs with RNF168
restores only recruitment of 53BP1 (NHEJ) but not BRCA1 (HR) to
the sites of DNA lesions, therefore stimulating the NHEJ pathway
(Hodge et al, 2016). Our results reported here and the recent discov-
ery that RNF168-knockout mice have a functional HR pathway
(Zong et al, 2019) further support the notion that the RNF8 signal-
ling cascade is enough for functional HR.
We observed increased amounts of RNF8/K63-ubiquitin signal at
sites of DNA damage in p97–ATX3-inactivated cells and attenuated
ubiquitination of histone H1 (in the first 30 min after IR), accompa-
nied by reduced RNF168 and 53BP1 recruitment. This raised the
question of why histone H1 cannot be ubiquitinated even when
RNF8 overaccumulates at damage sites (Thorslund et al, 2015).
Importantly, RNF8, but not RNF168, has been shown to unfold
higher-order chromatin structures (Luijsterburg et al, 2012). Thus,
we speculate that a high accumulation of RNF8 in the presence of
damage could make chromatin more accessible and affect histone
H1 ubiquitination. Interestingly, H1 is evicted from sites of DNA
damage (Sellou et al, 2016; Strickfaden et al, 2016), and recent
high-throughput mapping of histone modifications at DSBs showed
that breaks preferentially repaired by HR are enriched for ubiquitin
but limited in histone H1 occupancy (Clouaire et al, 2018). These
findings further support our observation that in ATX3-inactivated
cells, the HR pathway is functional (enrichment of K63-Ub at sites
of DSBs), but histone H1 is most probably not properly ubiquiti-
nated as it is evicted from unfolded chromatin around HR-processed
DSBs. However, further studies are required to address this impor-
tant question in the context of the p97–ATX3–RNF8 complex and
chromatin dynamics after DSB formation.
While our manuscript was in preparation, Pfeiffer et al (2017)
reported that ATX3 is a DUB acting at DSB sites and removes ubiq-
uitinated chains from MDC1 to prevent a premature removal of
MDC1 from the breaks. Thus, in accordance with Pfeiffer et al, in
ATX3-inactivated cells MDC1 is prematurely released from DNA
damage sites. This reduces the recruitment of downstream mole-
cules, such as RNF8 and RNF168 that are essential for both DSB
repair pathways, HR and NHEJ. However, under our experimental
conditions, we found that ATX3 forms a complex with RNF8 but not
MDC1. Moreover, we also analysed the role of ATX3 in regulating
RNF8 association with DNA damage sites. In various human cell
types, inactivation of ATX3 by either siRNA depletion or CRISPR/
Cas9 knockout led to recruitment and hyper-accumulation of RNF8
at the sites of DNA lesions induced by various sources of DNA
damage, such as IR, UV or two-photon micro-irradiation. This RNF8
hyper-accumulation was observed at different time points after
induction of DNA damage. We also observed an intact accumulation
of factors and signals downstream of RNF8, including BRCA1 and
K63-Ub, contrasting with findings reported by Pfeiffer et al.
However, our results regarding defective recruitment of RNF168 and
53BP1 to sites of DNA damage after ATX3 inactivation were similar
to those obtained by Pfeiffer et al.
In summary, our results suggest that ATX3 regulates p97-depen-
dent RNF8 extraction from, but not recruitment to, sites of DNA
lesions. Our findings are further supported by the fact that ATX3
inactivation selectively affects the NHEJ repair pathway, but not the
HR repair pathway, and that IR-exposed HR-deficient, but not NHEJ-
deficient, cancer cells are hypersensitive to ATX3 inactivation. Our
results thus suggest that targeting the p97–ATX3 complex could be a
promising strategy to radio-sensitise cancers, especially those that
are defective in homologous recombination repair.
Materials and Methods
Contact for reagents and resource sharing
Further information and requests for reagents should be directed to
the corresponding author: Kristijan Ramadan (kristijan.ra-
madan@oncology.ox.ac.uk).
Experimental model and subject details
Cell lines and cell culture procedure
The human HeLa (cervical cancer cell line), HEK293 and HEK293T
(embryonic kidney cell lines), U2OS (osteosarcoma cell line), MCF7
(adenocarcinoma mammary epithelial cell line) and DLD1 (colorec-
tal adenocarcinoma cell line) cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM, high glucose, GlutaMAX) with
10% FBS and penicillin–streptomycin antibiotics under standard cell
culture conditions. Cells were grown in a 5% CO2 incubator at 37°C
till 50–80% confluence before being used for experiments. Doxycy-
cline-inducible Flp-In T-REx cell lines were maintained in hygro-
mycin B (100 lg/ml)/blasticidin S (10 lg/ml)-containing medium,
and the expression of proteins was induced with doxycycline (1 lg/
ml) for 24 h. Cells were routinely tested for mycoplasma contamina-
tion. Sources of all the cell lines used in this study are provided as
follows:
Human: osteosarcoma
U-2 OS cells (female)
ATCC Cat# HTB-96, RRID:
CVCL_0042
Human: embryonic
kidney HEK293 cells
(female)
ATCC Cat# 300192/
p777_HEK293, RRID:
CVCL_0045
Human: cervical
carcinoma HeLa cells
(female)
ATCC Cat# CCL-2, RRID:
CVCL_0030
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Human: CRISPR D-ATX3
HeLa cells
This study N/A
Human: CRISPR D-ATX3
HEK293 cells
This study N/A
Human: CRISPR D-ATX3
U2OS cells
This study N/A
Human: HEK293-Flp-In
T-REx ATX3-WT-nEGFP
This study N/A
Human: HEK293-Flp-In
T-REx ATX3-C14A-nEGFP
This study N/A
Human: HEK293-Flp-In
T-REx ATX3-UIM-nEGFP
This study N/A
Human: HEK293-Flp-In
T-REx ATX3-VBM-nEGFP
This study N/A
Human: HEK293-Flp-In
T-REx p97-EQ-cSSH
Meerang et al (2011)
and Ritz et al (2011)
N/A
Human: U2OS-RNF8-
WT-nEGFP
Mailand et al (2007) N/A
Human: U2OS- RNF8-
RING-nEGFP
Mailand et al (2007) N/A
Human: CRISPR D-53BP1
MCF7 cells
Cuella-Martin et al
(2016)
N/A
Human: CRISPR D-
BRCA2 DLD1 cells
Zimmer et al (2016) N/A
Generation of doxycycline-inducible Flp-In T-REx stable cell lines
Doxycycline-inducible p97EQ HEK293-Flp-In T-REx stable cell lines
were generated as described perversely (Ritz et al, 2011). ATX3
variant (WT, C14A, UIM*) HeLa-Flp-In T-REx stable cell lines
(Thermo Fisher Scientific) were generated according to the manu-
facturer’s protocol for doxycycline-inducible expression of ATX3
variants. The ATX3-WT cDNA and mutants were amplified by PCR
and cloned into pcDNA5/FRT/TO-nEGFP vector (containing N-term-
inal GFP-tag) using BamH1 and Xho1 (NEW ENGLAND BioLabs)
restriction sites. The FRT/TO constructs were transfected with the
pOG44 vector into Flp-In host HeLa cells for site-specific integration
into the genome. The transformed cells were selected under hygro-
mycin B (150 lg/ml) to generate ATX3 HeLa-Flp-In T-REx stable
cell lines. The expression of ATX3 was confirmed by doxycycline
induction (1 lg/ml) followed by Western blot analysis, and three
different clones were selected for each variant.
Generation of CRISPR/Cas9 ATX3-knockout cells
Commercially available CRISPR/Cas9 KO plasmid containing three
guide RNAs targeting Ataxin 3, and a homology-directed repair plas-
mid containing a puromycin resistance cassette were purchased
from Santa Cruz Biotechnology. Plasmids (2.5 lg each) were trans-
fected into early-passage HEK293, HeLa and U2OS cells using
FuGENE HD (Promega Corporation). After 72 h of transfection, a
medium supplemented with puromycin was added to the cells. The
puromycin concentrations (1.25 lg/ml for HEK293 cells, 0.6 lg/ml
for HeLa cells and 1 lg/ml for U2OS cells) required to kill wild-type
cells were determined by puromycin kill curve. After 72 h, the puro-
mycin-containing medium was removed and cells were sorted using
a cell sorter into single-cell populations on a 96-well plate. ATX3
expression was analysed by Western blotting. Three HEK293, three
HeLa and three U2OS clones showing loss of all detectable ATX3
were selected for subsequent analysis.
Bacterial strains
Bacterial strain Escherichia coli DH5a (Thermo Fisher Scientific;
18265-017) was used for plasmid amplification and E. coli Rosetta 2
(DE3) (Novagen; 71405-3) for expression of recombinant proteins.
Antibodies
Antibodies used in this study are obtained as follows:
p97 (Rabbit polyclonal) Homemade Freire & Ramadan Labs
ATX3 (Mouse
monoclonal; C-1H9)
Merck Millipore Cat# MAB5360; RRID:
AB_2129339
ATX3 (Rabbit ATX3 full-
length polyclonal)
Homemade Freire & Ramadan Lab
RNF8 (Rabbit polyclonal) Proteintech Cat# 14112-1-AP*
RNF8 (Rabbit polyclonal) Homemade Ramadan Lab
Phospho-c-H2AX (Ser139)
(Rabbit polyclonal)
Novus Biologicals Cat# NB100-2280;
RRID:AB_10000580
Phospho- c-H2AX
(Ser139)
GeneTex Cat# GTX127342*
53BP1 (Rabbit polyclonal) Santa Cruz
Biotechnology
Cat# sc-22760; RRID:
AB_2256326
53BP1 (Mouse
monoclonal; C-19)
BD Biosciences Cat# 612523; RRID:AB_
399824
HA (Rabbit polyclonal) Santa Cruz
Biotechnology
Cat# sc-805; RRID:AB_
631618
HA [clone 3F10] (Rat
monoclonal)
Roche Cat# 3F10; RRID:AB_
2314622
PCNA (Mouse
monoclonal)
Abcam Cat# ab29; RRID:AB_
303394
Vinculin (Mouse
monoclonal; C-VIN54)
Abcam Cat# ab130007; RRID:
AB_11156698
Flag (Rabbit polyclonal) Sigma-Aldrich Cat# F7425; RRID:AB_
439687
MDC1 (Mouse
monoclonal; M2444)
Sigma-Aldrich Cat# M2444, RRID:AB_
532268
Ufd1(Rabbit polyclonal) Homemade Freire & Ramadan Labs
Npl4 (Rabbit polyclonal) Homemade Freire & Ramadan Labs
RNF168 (Rabbit
polyclonal)
Homemade Freire & Ramadan Labs
K48-Ub (Rabbit
monoclonal; C-Apu2)
Merck Millipore Cat# 05-1307; RRID:
AB_1587578
K48-Ub (human
monoclonal)
Genentech C-Apu2.07
K63-Ub (Rabbit
monoclonal; C-Apu3)
Merck Millipore Cat# 05-1308; RRID:
AB_1587580
K63-Ub (human
monoclonal)
Genentech C-Apu3.A8
FK2-Ub (Mouse
monoclonal; C-FK2)
Enzo Life Sciences Cat# BML-PW8810;
RRID:AB_10541840
Proteasomal Subunit a6 Enzo Life Sciences Cat# BML-PW8195,
RRID:AB_10541045
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RAP80 (Rabbit
polyclonal)
Bethyl Cat# A300-763A; RRID:
AB_669796
a-Tubulin (Mouse
monoclonal; DM1A)
Sigma-Aldrich Cat# T6199; RRID:AB_
477583
b-Actin (Mouse
monoclonal)
Abcam Cat# ab6276; RRID:AB_
2223210
RAD51 (Rabbit
polyclonal; H-92)
Santa Cruz
Biotechnology
Cat# sc-8349; RRID:
AB_2253533
BRCA1 (Mouse
monoclonal; C-D-9)
Santa Cruz
Biotechnology
Cat# sc-6954; RRID:AB_
626761
GFP (Goat polyclonal) Santa Cruz
Biotechnology
Cat# sc-5385, RRID:AB_
641121
Cyclin E [clone HE12]
(Mouse monoclonal)
Millipore Cat# 05-363; RRID:AB_
2071085
Cyclin A [clone H-432]
(Rabbit polyclonal)
Santa Cruz
Biotechnology
Cat# sc-751; RRID:AB_
631329
Lamin B1 (Rabbit
polyclonal)
Thermo Fisher
Scientific
Cat# PA5-19468; RRID:
AB_10985414
Anti-BRCA2 (Ab-1)
(Mouse monoclonal 2B)
Merck Millipore Cat# OP95, RRID:AB_
2067762
Phospho-RPA32 (S4/S8)
(Rabbit polyclonal)
Bethyl Cat# A300-245A; RRID:
AB_210547
Rabbit IgG, HRP-
conjugated (goat
polyclonal)
Sigma-Aldrich Cat# A9169; RRID:AB_
258434
Mouse IgG, HRP-
conjugated (rabbit
polyclonal)
Sigma-Aldrich Cat# A9044; RRID:AB_
258431
Rat IgG, HRP-conjugated
(goat polyclonal)
Bio-Rad Cat# 5204-2504; RRID:
AB_619913
Alexa Fluor 488, Goat
Anti-Mouse IgG (H+L)
Thermo Fisher
Scientific
Cat# (A-11001); RRID:
AB_2534069
Alexa Fluor 488, Goat
Anti-Rabbit IgG (H+L)
Thermo Fisher
Scientific
Cat# A-11034; RRID:
AB_2576217
Alexa Fluor 594, Goat
Anti-Mouse IgG (H+L)
Thermo Fisher
Scientific
Cat# A-11020; RRID:
AB_141974
Alexa Fluor 594, Goat
Anti-Rabbit IgG (H+L)
Thermo Fisher
Scientific
Cat# A-11012; RRID:
AB_2534079
Alexa Fluor 488, Goat
Anti-Human IgG (Fcc
fragment-specific)
Jackson
ImmunoResearch
Laboratories
Cat# 109-545-008;
RRID:AB_2337833
DyLight 488 goat anti-
human
Thermo Fisher
Scientific
Cat# SA5-10102; RRID:
AB_2556682
. *RRID for these antibodies could not be found.
Plasmids
Plasmids were transfected using polyethyleneimine (PEI) reagent or
FuGENE HD transfection reagent (Promega), and the medium was
changed after 4 h of plasmid transfection to avoid the toxicity. The
expression of plasmids was allowed for 24–48 h, and cells were
harvested. In the case of U2OS cells, the plasmids were transfected
with Lipofectamine 3000 reagent (Thermo Fisher Scientific) accord-
ing to the manufacturer’s protocol. All the plasmids used in this
study are listed as follows:
pCDNA5-FRT/TO-nEGFP Vaz et al (2016) N/A
pFLAG-6a-Ataxin3Q22(Wt) Addgene Cat#
22126
pFLAG-6a-Ataxin3Q22-C14A Addgene Cat#
22127
pFLAG-6a-Ataxin3Q22-UIM* Addgene Cat#
22128
pFLAG-6a-Ataxin3Q22-VBM* This paper N/A
pCDNA5-FRT/TO-ATX3-Wt-nEGFP This paper N/A
pCDNA5-FRT/TO-ATX3-C14A-nEGFP This paper N/A
pCDNA5-FRT/TO-ATX3-UIM-nEGFP This paper N/A
p3XFLAG-CMV-7.1 Sigma-Aldrich Cat#
E7533
pcDNA4/TO FLAG-RNF8 Mailand et al (2007) N/A
pcDNA4/TO FLAG-Ring* Mailand et al (2007) N/A
p3XFLAG-CMV-7.1_H1 Gift from M. Gyrd-
Hansen
N/A
pcDNA5 p97-Wt (Strep-myc)-amp Meerang et al
(2011)
N/A
pcDNA5 p97-EQ (Strep-myc)-amp Meerang et al
(2011)
N/A
pcDNA HA-Ubiquitin Gift from H. Meyer N/A
pCDNA5- FRT/TO-ATX3-VBM-nEGFP
(RKRR-AAAA)
Ramadan Lab N/A
siRNAs
The siRNA duplexes for the control (luciferase) or against the indi-
cated gene were transfected using Lipofectamine RNAiMAX reagent
(Thermo Fisher Scientific) according to the manufacturer’s protocol,
and depletion efficiency was assayed at 48–72 h post-transfection.
All the siRNAs used in this study are listed as follows:
siRNA_Luciferase (CGUACGCGGAAUACUUCGA) Microsynth
siRNA_p97#1 (AACAGCCAUUCUCAAACAGAA) Meerang et al
(2011)
siRNA_p97#2 (AAGUAGGGUAUGAUGACAUUG) Meerang et al
(2011)
siRNA_ATX3#1 (GGACAGAGUUCACAUCCAU) ON-Target;
Dharmacon
siRNA_ATX3#2 (ACAGGAAGGUUAUUCUAUA) ON-Target;
Dharmacon
siRNA_ATX3#3 (GCAGGGCUAUUCAGCUAAG) ON-Target;
Dharmacon
siRNA_ATX3#4 (UGCGUCGGUUGUAGGACUAAA) QIAGEN
siRNA_ATX3#5 (GGAAUGUAGGUGUCUGCUU) against
30UTR
Microsynth
siRNF8 (GGACAAUUAUGGACAACAA) Mailand et al
(2007)
siRNF168 (GGCGAAGAGCGAUGGAAGA) Doil et al (2009)
siDNA-PK (GCGUUGGAGUGCUACAACA) ON-Target;
Dharmacon
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siRAD51 (GAAGCUAUGUUCGCCAUUA)
(GCAGUGAUGUCCUGGAUAA)
ON-Target;
Dharmacon
siNpl4 (CAGCCUCCUCCAAGAAAUC) Meerang et al
(2011)
siUfd1 (GUGGCCACCUACUCCAAAU) Meerang et al
(2011)
Preparation of cell lysates
Cells were washed twice with ice-cold PBS and subsequently
lysed with RIPA buffer (25 mM Tris–HCl, pH 7.4, 150 mM NaCl,
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100) freshly
supplemented with phosphatase and protease inhibitors (ROCHE).
The deubiquitinating enzymes were also blocked with freshly
prepared NEM (Thermo Scientific). Cell lysates were sonicated
using the Bioruptor (Diagenode) at high intensity for 30 s on/30 s
off cycles for 10 min to shear the DNA. Cell lysates were centri-
fuged at 14,000 g for 10 min at 4°C, and the supernatant was
collected.
Cellular fractionation
With regard to specific subcellular fractions, the cells were frac-
tionated as described previously (Mendez & Stillman, 2000). In
brief, the cytoplasmic fraction was isolated by suspending cells in
buffer A (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol) freshly supplemented with protease and
phosphatase inhibitors, NEM and 0.1% Triton X-100. Nuclei were
ruptured to release the nucleoplasm using hypotonic buffer B
(10 mM HEPES, 3 mM EDTA, 0.2 mM EGTA, pH 8.0). The chro-
matin was washed with benzonase buffer (25 mM Tris–HCl, pH
8.0, 20 mM NaCl, 2 mM MgCl2) and digested with benzonase
(500 U/ml) while rotating at 10 rpm for 30 min at room tempera-
ture. Protein concentrations were measured using the RC DC
Protein Assay Kit (Bio-Rad).
Western blot
Cell lysates were denatured by boiling with Laemmli buffer
containing beta-mercaptoethanol and separated on sodium dode-
cyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE) as
per standard protocols. Proteins were transferred to PVDF (Bio-
Rad) or nitrocellulose membrane (GE Healthcare) and detected
by immunoblotting. The membranes were blocked with 5% milk
and incubated overnight with primary antibodies (5% BSA in
TBS–Tween buffer, pH 7.4) at 4°C. After three subsequent wash-
ings, secondary antibodies coupled with HRP were incubated for
1 h at room temperature and the specific protein band detected
by ECL-based chemiluminescence with Bio-Rad gel documenta-
tion system.
Ionising radiation
Cells were exposed to the indicated gray (Gy) of ionising radiation
using a 137caesium source (Gamma-Service Medical GmbH) at a
dose rate of 1.3 Gy/min. Cells were left to recover in a 5% CO2 incu-
bator at 37°C for the recovery times as indicated.
Two-photon absorbed laser spot-induced DNA damage
Cells were presensitised with Hoechst (10 lg/ml) for 30 min in Ibidi
l-Dish 35 mm high Glass Bottom dishes. Cells were treated with
indicated siRNAs for 3 days then FluoroBrite DMEM was added and
cells placed on heated stage 37°C, 5% CO2. Single spot micro-irra-
diation was achieved using a 100-fs-pulse width laser, operating at
an 80 MHz repetition rate (Mai-Tai DeepSee, Spectra Physics, UK)
tuned to 750 nm, power set to 7.5–10 mW, the dwell time of laser
was 1.58 ls. Power was measured before each irradiation experi-
ment using a Coherent FieldMate with PM10 head. The 2-photon
energy per single spot of 1.58 ls and 10 mW average power. Laser
energy on the sample (spot) is typically < 16 nJ. Bleaching settings
was used in Zeiss ZEN software and Zeiss LSM 710 was used at
63×/1.4 objective to image the cells. Images were analysed using
FIJI, and RNF8-GFP recruitment was normalised to background
levels in the irradiated cells. Recruitment was quantified relative to
0 s time point, which was set as 1 unit of relative fluorescent inten-
sity.
UV-laser micro-irradiation
Cells were line-micro-irradiated using a built in-house UV-laser
system based around a UV-A (355 nm) Q-switched Nd:YAG laser
(MiniliteTM II) that produced pulses of 5 ns duration. The laser beam
was expanded by a 10× beam expander (Edmund #68-272) and
passed through a bandpass filter (Semrock FF01-360/12-25) and an
nominal OD1 reflective filter (Thorlabs NDUV10B) and then focused
onto a slit with a cylindrical lens (Elliott CYLX-25.4X25.4U300,
f = 300 mm). The slit passed the required laser energy and was re-
imaged onto the sample with a tube lens (Thorlabs LA4855-UV) and
a 10×/0.5 objective (Nikon CFI Super Fluor). The slit height was
adjusted such that the slit covered the imaged field of view and its
width adjusted to provide a line width of ~ 450 nm fullwidth at
half-maximum. The microscope body (Nikon TE2000) was modified
to accept the additional tube lens, and imaging was performed using
the TE2000’s f = 200 mm tube lens onto a sCMOS camera (Hama-
matsu Orca Flash4.0). Cells were seeded onto 10-mm No. 1 cover
glasses (VWR) and sensitised using 10 lg/ml Hoechst 33258
(Sigma) added 30 min prior to laser illumination. Coverslips were
subsequently transferred into in-house-made glass-bottom dishes
containing complete medium. Each laser line was generated with a
single pulse, and the sample stage was moved by 25 lm after every
pulse using a motorised stage (Ma¨rzha¨user SCAN IM). Typically,
the imaged field could be covered by 50 laser lines. Laser energy
pulse–pulse reproducibility was monitored by an in-house energy
sensor based around pyroelectric (Scitec PEO8) sensor and a CFQ-
1520 quartz coverslip pick off. Laser energy on the sample was
adjusted on the laser’s variable attenuator to be typically  10 lJ
across the line. Following laser irradiation, cover glasses were trans-
ferred in 12-well plates containing complete medium and incubated
in a 5% CO2 incubator at 37°C for indicated recovery times.
Colony formation assay
Cell survival after ionising radiation was determined by slandered
clonogenic assay. In brief, appropriate numbers of cells were seeded
in 6-well plates and incubated overnight. Cells were exposed to the
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indicated dose of ionising radiation and incubated in a 5% CO2 incu-
bator at 37°C for 7–10 days to form colonies (at least 50 cells per
colony). The colonies were fixed and stained with crystal violet
(Sigma) solution in methanol for 20 min at room temperature. After
washing and drying, the colonies were counted manually or by
automated colony counter GelCountTM (DTI-Biotech). Results were
normalised to plating efficiency, and the number of colonies in irra-
diated samples was expressed as a percentage of non-irradiated
samples.
Immunofluorescence
Immunofluorescence was performed as previously described
(Meerang et al, 2011). Briefly, cells were fixed with 4% PFA in PBS
for 15 min at RT followed by permeabilisation with 0.5% Trion X-
100 (Sigma). If necessary, pre-extraction was performed for 2 min
on ice using pre-extraction buffer (25 mM HEPES pH 7.4, 50 mM
NaCl, 1 mM EDTA, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton X-
100, protease and phosphatase inhibitors) prior to fixation. Cells
were blocked with 5% BSA overnight at 4°C. Antibodies were
diluted in 2.5% BSA in PBS at specific dilutions and left for 1 h at
room temperature. DNA was stained with DAPI and cells were
mounted with FluoroMount-G hard mounting medium (Interchim).
Microscopy and image quantifications
Nikon 90i epifluorescent microscope equipped with a Nikon DS-
Qi1Mc digital microscope camera was used to take the entire IF
images. Images were captured using a 60× objective and exported as
a TIFF file. The Image analysis was performed using ImageJ soft-
ware. For laser line analysis, intensity at the site of DNA damage
was analysed by circling the c-H2AX signal and measuring the
intensity of the protein of interest at that area. From the same
nucleus, a measurement of the background signal was also taken
and subtracted from the intensity of the damage area. All measure-
ments were normalised to control for each time points to compare
between different siRNA-depleted conditions.
Protein co-immunoprecipitations (Co-IPs)
Cells were transfected with the plasmids of interest using PEI. After
treatment (according to the experiment), cells were collected by
trypsinisation and rinsed twice with ice-cold PBS. Cells were lysed
using IP lysis buffer (50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM
EDTA, 0.5–1% Triton X-100, protease and phosphatase inhibitors).
The pellets were washed once with benzonase buffer (2 mM MgCl2,
50 mM Tris–HCl pH 8.0, 20 mM NaCl, Inhibitors) and then incubated
in benzonase buffer containing benzonase (500 U/ml) at 4°C until
the DNA was digested. Lysates were loaded onto beads (GFP: Chro-
motek; Flag: Sigma; Strep-Tactin: IBA) and capturing was performed
according to the manufacturer’s protocol. Proteins were eluted in
Laemmli sample buffer (2×) and analysed by Western blotting.
Denaturing immunoprecipitations (Denaturing-IPs)
Cells were transfected with the plasmids of interest using PEI or
FuGENE HD Transfection Reagent (Promega). After treatment (ac-
cording to the experiment), cells were collected by trypsinisation
and rinsed twice with ice-cold PBS. Cells were lysed with 1% SDS
and heated to 95°C for 5 min to denature the proteins. The excess of
SDS was quenched with 1% Triton X-100 and the DNA was sheared
with a 22-G needle. Cell lysate was centrifuged at high speed to
remove the cell debris and the supernatant was incubated with Flag
beads at 4°C for 2–4 h. The beads were washed one time with 1 M
NaCl/1% Triton X-100 followed by two washes with 150 mM NaCl/
1% Triton X-100 and the bound protein was eluted with Laemmli
sample buffer (2×) and analysed by Western blotting.
SILAC and mass spectrometry
For quantitative mass spectrometry, Flp-In T-REx HEK293T/p97-
E578Q-Strep cell lines were first SILAC labelled. After induction of
p97-E578Q-Strep with doxycycline and treatment with 10 Gy of
ionising radiation, a nuclear fraction was extracted, treated with
benzonase, and the p97 interactors in this fraction were pulled
down with Strep-Tactin beads (IBA). After purification, pulled-down
proteins were prepared for mass spectrometry including digestion
with Trypsin (Promega), and analysed by LC-MS/MS, followed by
determination of SILAC ratios by Proteome Discoverer software
(Thermo). Results from a subgroup of proteasomal and p97-cofactor
proteins were selected for this study.
Cloning and mutagenesis
ATX3-WT, C14A and UIM* variants cDNAs were amplified by Accu-
Prime Pfx DNA polymerase (Invitrogen) using Veriti 96-well thermal
cycler (Applied Biosystems). Plasmids pFLAG-6A-ATX3Q_22 (WT),
C14A and UIM* from Addgene were used as templates to amplify
the cDNAs. The cDNAs were cloned in pCDNA5-FRT/TO-nEGFP
vector using BamH1 and Xho1 restriction endonucleases (NEW
ENGLAND BioLabs) and confirmed by DNA sequencing (Source
Biosciences). ATX3 variants were generated by site-directed mutage-
nesis using AccuPrime Pfx DNA polymerase (Invitrogen) according
to the manufacturer’s protocol and confirmed by DNA sequencing
(Source Biosciences). List of PCR and mutagenic primers is provided
as follows.
ATXN3_BamH1_F (ATATGGATCCATGGAGTC
CATCTTCCACGAG)
This study (PCR)
ATXN3_Xho1_R (ATATCTCGAGTTATT
TTTTTCCTTCTGTTTTCAAATCATTTCTG)
This study (PCR)
ATXN3_VBMRKRR285AKAR_R (ATCAGGT
ACAAATCTTACTTCAGAAGAGCT
TGCGAAGGCACGAGAAGCCTACTTT)
This study
(mutagenesis)
ATXN3_VBMAKAR285AAAA_F
(CTTCAGAAGAGCTTGCGGCGGCAGCAG
AAGCCTACTTTGAAAAAC)
This study
(mutagenesis)
ATXN3_VBMAKAR285AAAA_R
(GTTTTTCAAAGTAGGCTTCTGCTGCCG
CCGCAAGCTCTTCTGAAG)
This study
(mutagenesis)
Reverse transcription–polymerase chain reaction
Total RNAs were isolated from cells using GeneJET RNA purifica-
tion kit (Thermo Fisher Scientific; K0731) and converted to cDNA
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using SuperScriptTM II Reverse Transcriptase (Invitrogen; 18064014).
Reverse transcription–polymerase chain reaction (RT–PCR) was
performed on StepOnePlus RT–PCR system (Applied Biosystem)
with gene-specific primers using Fast SYBR Green Master Mix
(Thermo Fisher Scientific; 4385612). List of gene-specific primers
used for RT–PCR in this study is provided as follows:
Human_ATXN3_ Forward RT Primer
(GCACGTTTTTACAGCAGCCTT)
This study (RT–PCR)
Human_ATXN3_ Reverse RT Primer
(AGCCTCTGATACTCTGGACTGT)
This study (RT–PCR)
Human_RNF8_ Forward RT Primer_P1
(TTGAGGCTGTCACCTTGAACT)
This study (RT–PCR)
Human_ RNF8_ Reverse RT Primer_P1
(TGTCCTTCCGACAAATGGGG)
This study (RT–PCR)
Human_ RNF8_ Forward RT Primer_P2
(TCGCAGCAAGAAGGACTTTGA)
This study (RT–PCR)
Human_ RNF8_ Forward RT Primer_P2
(AGTTCAAGGTGACAGCCTCAAT)
This study (RT–PCR)
Comet assay
HeLa cells were treated with 20 nM non-targeting control siRNA
(Qiagen) or ATXN3 siRNA for 48 h, trypsinised and irradiated in
suspension at 4 Gy using a CellRad X-ray irradiator (Faxitron). Cells
were embedded in agarose on a microscope slide, incubated for up
to 4 h in a humidified chamber and levels of DNA double-strand
breaks measured using the neutral comet assay, as previously
described (Nickson et al, 2017; Carter et al, 2018).
Reporter assay
DSB repair efficiency was measured as described previously (Ben-
nardo et al, 2008). In brief, 0.2 × 106 cells were seeded and treated
with different siRNAs. The next day cells were transfected with the
pCBASceI plasmid and allowed to grow for 4 days. GFP was
measured by flow cytometry performed on a FACSCalibur instru-
ment (BD Biosciences).
Other reagents
List of chemicals, peptides and recombinant proteins used in this
study is provided as follows:
CB-5083 Selleckchem.com Cat# S8101
NMS873 Selleckchem.com Cat# S7285
DBeQ Selleckchem.com Cat# S7199
Cycloheximide Sigma Cat# C1988
MG132 Selleckchem.com Cat# S2619
5-Ethynyl-20-deoxyuridine
(EdU)
Sigma-Aldrich Cat# T511285
5-Bromo-20-deoxyuridine
(BrdU)
Sigma-Aldrich Cat# B9285
Ampicillin Fisher Scientific Cat# BP1760
Blasticidin S Thermo Fisher Scientific Cat# A1113903
Hygromycin B TOKU-E Cat#
SKU: H007
Doxycycline PanReac AppliChem Cat#
A2951,0025
AccuPrime Pfx DNA
polymerase
Invitrogen Cat# 12344-
024
Lipofectamine siRNAMax Invitrogen Cat# 13778-
150
Polyethylenimine Sigma-Aldrich Cat# 408727
Benzonase Millipore Cat# 71205
Kanamycin Thermo Fisher Scientific Cat# 11815024
Strep-Tactin Sepharose IBA Cat# 2-1201-
010
Penicillin–Streptomycin Sigma Cat# P4333
ANTI-FLAG® M2 Affinity Gel Sigma Cat# A2220
GFP-Trap®_A Chromotek Cat# GTA-
500 ll
NEM Sigma-Aldrich, Thermo
Fisher Scientific
Cat# E3876-
25GNEM
FuGENE HD Transfection
Reagent
Promega Cat# E2311
Critical commercial assays
List of critical chemical assays used in this study is provided as follows:
ClarityTM Western ECL
Substrate
Bio-Rad Cat# 1705061
SuperSignalTM West Femto
Maximum Sensitivity
Substrate
Thermo Fisher
Scientific
Cat# 34095
SuperSignalTM West Pico
PLUS Chemiluminescent
Substrate
Thermo Fisher
Scientific
Cat# 34580
DCTM Protein Assay Kit II Bio-Rad Cat# 5000112
Plasmid DNA Purification
Kit
QIAGEN Cat# 12163
Gel Extraction Kit QIAGEN Cat# 28604
PCR Purification Kit QIAGEN Cat# 28104
QuikChange II Site-
Directed Mutagenesis Kit
Agilent Cat# 200523
GeneJET RNA purification
kit
Thermo Fisher
Scientific
Cat# K0731
Fast SYBR Green Master
Mix
Thermo Fisher
Scientific
Cat# 4385612
SuperScriptTM II Reverse
Transcriptase
Thermo Fisher
Scientific
Cat# 18064014
Quantification and statistical analysis
Statistical analysis was performed using GraphPad Prism software.
Unpaired t-tests and one- or two-way ANOVAs were performed as
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mentioned in the Figure legends. P values refer to: ****P < 0.0001,
***P < 0.001, **P < 0.01, *P < 0.05, nsP > 0.05. For IF micrographs
the scale bar is 10 lm and at least 100 nuclei were quantified per
condition per experiment unless mentioned.
Expanded View for this article is available online.
Acknowledgements
The Ramadan Laboratory is supported by a Medical Research Council UK
programme grant (MC_EX_MR/K022830/1) to K.R. J.O. was supported by a
Swiss National Science Foundation grant (31003A_141197) to K.R., a Goodger
and Schorstein Scholarship, University of Oxford, and a European Institute of
Innovation and Technology short-term post-doctoral fellowship. S. K, J. F. and
S. L were supported by the Cancer Research UK or MRC studentships. B. Vo.,
A. E. K. and I. D. C. T. are supported by Cancer Research UK Programme
Grant C5255/A15935. C.G. was supported by the Danish Cancer Society (Grant
No. R146-RP11394). R. F. is supported by Spanish Ministry of Innovation
Science and Universities/EU-ERDF (SAF2016-80626-R), E. C. is supported by
the Fundación DISA, and E. H-C. is supported by an ACIISI pre-doctoral
fellowship. We thank Ross Chapman for providing us with WT and 53BP1-
deficient MCF7 cell lines. We are grateful to Pam Reynolds for support with
the UV micro-irradiation system, to the Mechanical and Electronics Work-
shops (J Prentice and RG Newman) for assistance with construction of the
system, to the Bioanalysis Core (Graham Brown and Ioland Vendrell) for the
supports with microscopy and mass spectrometry and to the Radiation
Biophysics Core for the help with X-ray radiation. We thank Benedikt Kessler
for his constant support with mass spectrometry. We thank Jeremy Stark for
providing us with GFP-reporter assays for HR and NHEJ.
Author contributions
JO and ANS performed the majority of the experiments. IT performed a SILAC-
based p97 proteome. SK and AEK performed and analysed end-resection assay.
SL performed two-photon laser-induced DNA damage live imaging. BVa anal-
ysed DNA repair reporter assays. CG and NM investigated GFP-RNF8 foci
formation, and JF created ATX3-ko cells. IDCT, JO, PRB and BVo designed, opti-
mised and calibrated in-house UV-laser micro-irradiation system. EH-C, EC
and RF performed cell cycle analysis and created rabbit anti-human ATX3 anti-
body. JP performed comet assay, and MM initially observed the role of p97 in
the stability of RNF8 and contributed with Fig 1C. KR conceived and super-
vised the project. JO, ANS and KR jointly wrote and prepared the manuscript.
All the authors discussed the results.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Ackermann L, Schell M, Pokrzywa W, Kevei E, Gartner A, Schumacher B,
Hoppe T (2016) E4 ligase-specific ubiquitination hubs coordinate DNA
double-strand-break repair and apoptosis. Nat Struct Mol Biol 23:
995 – 1002
Acs K, Luijsterburg MS, Ackermann L, Salomons FA, Hoppe T, Dantuma NP
(2011) The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing
L3MBTL1 from DNA double-strand breaks. Nat Struct Mol Biol 18:
1345 – 1350
Aparicio T, Baer R, Gautier J (2014) DNA double-strand break repair pathway
choice and cancer. DNA Repair (Amst) 19: 169 – 175
Baranes-Bachar K, Levy-Barda A, Oehler J, Reid DA, Soria-Bretones I, Voss TC,
Chung D, Park Y, Liu C, Yoon JB et al (2018) The ubiquitin E3/E4 ligase
UBE4A adjusts protein ubiquitylation and accumulation at sites of
DNA damage. Facilitating double-strand break repair. Mol Cell 69:
866 – 878 e7
Bennardo N, Cheng A, Huang N, Stark JM (2008) Alternative-NHEJ is a
mechanistically distinct pathway of mammalian chromosome break
repair. PLoS Genet 4: e1000110
Bergink S, Ammon T, Kern M, Schermelleh L, Leonhardt H, Jentsch S (2013)
Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52
interaction. Nat Cell Biol 15: 526 – 532
Bodnar N, Rapoport T (2017a) Toward an understanding of the Cdc48/p97
ATPase. F1000Res 6: 1318
Bodnar NO, Rapoport TA (2017b) Molecular mechanism of substrate
processing by the Cdc48 ATPase complex. Cell 169: 722 – 735 e9
van den Boom J, Wolf M, Weimann L, Schulze N, Li F, Kaschani F, Riemer A,
Zierhut C, Kaiser M, Iliakis G et al (2016) VCP/p97 extracts sterically
trapped Ku70/80 rings from DNA in Double-strand break repair. Mol Cell
64: 189 – 198
Buchberger A, Schindelin H, Hanzelmann P (2015) Control of p97 function by
cofactor binding. FEBS Lett 589: 2578 – 2589
Bug M, Meyer H (2012) Expanding into new markets–VCP/p97 in endocytosis
and autophagy. J Struct Biol 179: 78 – 82
Burnett B, Li F, Pittman RN (2003) The polyglutamine neurodegenerative
protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin
protease activity. Hum Mol Genet 12: 3195 – 3205
Carter RJ, Nickson CM, Thompson JM, Kacperek A, Hill MA, Parsons JL (2018)
Complex DNA damage induced by high linear energy transfer alpha-
particles and protons triggers a specific cellular DNA damage response. Int
J Radiat Oncol Biol Phys 100: 776 – 784
Chang HHY, Pannunzio NR, Adachi N, Lieber MR (2017) Non-homologous
DNA end joining and alternative pathways to double-strand break repair.
Nat Rev Mol Cell Biol 18: 495 – 506
Chapman JR, Taylor MR, Boulton SJ (2012) Playing the end game: DNA
double-strand break repair pathway choice. Mol Cell 47: 497 – 510
Chou TF, Brown SJ, Minond D, Nordin BE, Li K, Jones AC, Chase P, Porubsky
PR, Stoltz BM, Schoenen FJ et al (2011) Reversible inhibitor of p97, DBeQ,
impairs both ubiquitin-dependent and autophagic protein clearance
pathways. Proc Natl Acad Sci USA 108: 4834 – 4839
Chou TF, Bulfer SL, Weihl CC, Li K, Lis LG, Walters MA, Schoenen FJ, Lin HJ,
Deshaies RJ, Arkin MR (2014) Specific inhibition of p97/VCP ATPase and
kinetic analysis demonstrate interaction between D1 and D2 ATPase
domains. J Mol Biol 426: 2886 – 2899
Clouaire T, Rocher V, Lashgari A, Arnould C, Aguirrebengoa M, Biernacka A,
Skrzypczak M, Aymard F, Fongang B, Dojer N et al (2018) Comprehensive
mapping of histone modifications at DNA double-strand breaks deciphers
repair pathway chromatin signatures. Mol Cell 72: 250 – 262 e6
Collins GA, Goldberg AL (2017) The logic of the 26S proteasome. Cell 169:
792 – 806
Cuella-Martin R, Oliveira C, Lockstone HE, Snellenberg S, Grolmusova N,
Chapman JR (2016) 53BP1 integrates DNA repair and p53-dependent cell
fate decisions via distinct mechanisms. Mol Cell 64: 51 – 64
Dantuma NP, Groothuis TA, Salomons FA, Neefjes J (2006) A dynamic
ubiquitin equilibrium couples proteasomal activity to chromatin
remodeling. J Cell Biol 173: 19 – 26
Dantuma NP, Acs K, Luijsterburg MS (2014) Should I stay or should I go: VCP/
p97-mediated chromatin extraction in the DNA damage response. Exp Cell
Res 329: 9 – 17
ª 2019 The Authors The EMBO Journal e102361 | 2019 23 of 25
Abhay Narayan Singh et al The EMBO Journal
Dev H, Chiang TW, Lescale C, de Krijger I, Martin AG, Pilger D, Coates J,
Sczaniecka-Clift M, Wei W, Ostermaier M et al (2018) Shieldin complex
promotes DNA end-joining and counters homologous recombination in
BRCA1-null cells. Nat Cell Biol 20: 954 – 965
Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R,
Ellenberg J, Panier S, Durocher D, Bartek J et al (2009) RNF168 binds and
amplifies ubiquitin conjugates on damaged chromosomes to allow
accumulation of repair proteins. Cell 136: 435 – 446
Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K (2003) Ataxin-3
interactions with rad23 and valosin-containing protein and its
associations with ubiquitin chains and the proteasome are consistent
with a role in ubiquitin-mediated proteolysis. Mol Cell Biol 23: 6469 – 6483
Feng L, Chen J (2012) The E3 ligase RNF8 regulates KU80 removal and NHEJ
repair. Nat Struct Mol Biol 19: 201 – 206
Friedberg EC, Aguilera A, Gellert M, Hanawalt PC, Hays JB, Lehmann AR,
Lindahl T, Lowndes N, Sarasin A, Wood RD (2006) DNA repair: from
molecular mechanism to human disease. DNA Repair (Amst) 5: 986 – 996
Gatti M, Pinato S, Maiolica A, Rocchio F, Prato MG, Aebersold R, Penengo L
(2015) RNF168 promotes noncanonical K27 ubiquitination to signal DNA
damage. Cell Rep 10: 226 – 238
Gudjonsson T, Altmeyer M, Savic V, Toledo L, Dinant C, Grofte M, Bartkova J,
Poulsen M, Oka Y, Bekker-Jensen S et al (2012) TRIP12 and UBR5 suppress
spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150:
697 – 709
Hodge CD, Ismail IH, Edwards RA, Hura GL, Xiao AT, Tainer JA, Hendzel MJ,
Glover JN (2016) RNF8 E3 ubiquitin ligase stimulates Ubc13 E2
conjugating activity that is essential for DNA double strand break
signaling and BRCA1 tumor suppressor recruitment. J Biol Chem 291:
9396 – 9410
Hustedt N, Durocher D (2016) The control of DNA repair by the cell cycle. Nat
Cell Biol 19: 1 – 9
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and
disease. Nature 461: 1071 – 1078
Jeggo PA, Geuting V, Lobrich M (2011) The role of homologous recombination in
radiation-induced double-strand break repair. Radiother Oncol 101: 7 – 12
Jeggo PA, Lobrich M (2015) How cancer cells hijack DNA double-strand break
repair pathways to gain genomic instability. Biochem J 471: 1 – 11
Jeggo PA, Pearl LH, Carr AM (2016) DNA repair, genome stability and cancer:
a historical perspective. Nat Rev Cancer 16: 35 –42
Kim H, Chen J, Yu X (2007) Ubiquitin-binding protein RAP80 mediates BRCA1-
dependent DNA damage response. Science 316: 1202 – 1205
Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, Panier
S, Mendez M, Wildenhain J, Thomson TM et al (2007) Orchestration of the
DNA-damage response by the RNF8 ubiquitin ligase. Science 318:
1637 – 1640
Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, Wang X, Meng S, Lei L, Xu L et al
(2016) RNF8 promotes epithelial-mesenchymal transition of breast cancer
cells. J Exp Clin Cancer Res 35: 88
Laco MN, Cortes L, Travis SM, Paulson HL, Rego AC (2012) Valosin-containing
protein (VCP/p97) is an activator of wild-type ataxin-3. PLoS ONE 7:
e43563
Lee HJ, Li CF, Ruan D, Powers S, Thompson PA, Frohman MA, Chan CH
(2016a) The DNA damage transducer RNF8 facilitates cancer
chemoresistance and progression through twist activation. Mol Cell 63:
1021 – 1033
Lee HJ, Ruan D, He J, Chan CH (2016b) Two-faced activity of RNF8: what
“twists” it from a genome guardian to a cancer facilitator? Mol Cell Oncol
3: e1242454
Livingstone M, Ruan H, Weiner J, Clauser KR, Strack P, Jin S, Williams A,
Greulich H, Gardner J, Venere M et al (2005) Valosin-containing protein
phosphorylation at Ser784 in response to DNA damage. Can Res 65:
7533 – 7540
Lok GT, Sy SM, Dong SS, Ching YP, Tsao SW, Thomson TM, Huen MS (2012)
Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-
ubiquitylation. Nucleic Acids Res 40: 196 – 205
Luijsterburg MS, Acs K, Ackermann L, Wiegant WW, Bekker-Jensen S, Larsen
DH, Khanna KK, van Attikum H, Mailand N, Dantuma NP (2012) A new
non-catalytic role for ubiquitin ligase RNF8 in unfolding higher-order
chromatin structure. EMBO J 31: 2511 – 2527
Magnaghi P, D’Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, Gasparri F,
Cozzi L, Cucchi U, Orrenius C et al (2013) Covalent and allosteric
inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat Chem Biol
9: 548 – 556
Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas
J (2007) RNF8 ubiquitylates histones at DNA double-strand breaks and
promotes assembly of repair proteins. Cell 131: 887 – 900
Mallette FA, Mattiroli F, Cui G, Young LC, Hendzel MJ, Mer G, Sixma TK,
Richard S (2012) RNF8- and RNF168-dependent degradation of KDM4A/
JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J 31:
1865 – 1878
Matos CA, Nobrega C, Louros SR, Almeida B, Ferreiro E, Valero J, Pereira de
Almeida L, Macedo-Ribeiro S, Carvalho AL (2016) Ataxin-3 phosphorylation
decreases neuronal defects in spinocerebellar ataxia type 3 models. J Cell
Biol 212: 465 – 480
Mattiroli F, Vissers JH, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, Marteijn
JA, Sixma TK (2012) RNF168 ubiquitinates K13-15 on H2A/H2AX to drive
DNA damage signaling. Cell 150: 1182 – 1195
Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, Janscak P,
Hubscher U, Meyer H, Ramadan K (2011) The ubiquitin-selective
segregase VCP/p97 orchestrates the response to DNA double-strand
breaks. Nat Cell Biol 13: 1376 – 1382
Mendez J, Stillman B (2000) Chromatin association of human origin
recognition complex, cdc6, and minichromosome maintenance proteins
during the cell cycle: assembly of prereplication complexes in late mitosis.
Mol Cell Biol 20: 8602 – 8612
Meyer H, Bug M, Bremer S (2012) Emerging functions of the VCP/p97 AAA-
ATPase in the ubiquitin system. Nat Cell Biol 14: 117 – 123
Meyer H, Weihl CC (2014) The VCP/p97 system at a glance: connecting
cellular function to disease pathogenesis. J Cell Sci 127: 3877 – 3883
Munoz MC, Laulier C, Gunn A, Cheng A, Robbiani DF, Nussenzweig A, Stark
JM (2012) RING finger nuclear factor RNF168 is important for defects in
homologous recombination caused by loss of the breast cancer
susceptibility factor BRCA1. J Biol Chem 287: 40618 – 40628
Nakada S, Yonamine RM, Matsuo K (2012) RNF8 regulates assembly of RAD51
at DNA double-strand breaks in the absence of BRCA1 and 53BP1. Can Res
72: 4974 – 4983
Nickson CM, Moori P, Carter RJ, Rubbi CP, Parsons JL (2017) Misregulation of
DNA damage repair pathways in HPV-positive head and neck squamous
cell carcinoma contributes to cellular radiosensitivity. Oncotarget 8:
29963 – 29975
Noordermeer SM, Adam S, Setiaputra D, Barazas M, Pettitt SJ, Ling AK, Olivieri
M, Alvarez-Quilon A, Moatti N, Zimmermann M et al (2018) The shieldin
complex mediates 53BP1-dependent DNA repair. Nature 560: 117 – 121
Panier S, Durocher D (2013) Push back to respond better: regulatory
inhibition of the DNA double-strand break response. Nat Rev Mol Cell Biol
14: 661 – 672
24 of 25 The EMBO Journal e102361 | 2019 ª 2019 The Authors
The EMBO Journal Abhay Narayan Singh et al
Paul A, Wang B (2017) RNF8- and Ube2S-dependent ubiquitin lysine 11-
linkage modification in response to DNA damage. Mol Cell 66: 458 – 472 e5
Pfeiffer A, Luijsterburg MS, Acs K, Wiegant WW, Helfricht A, Herzog LK,
Minoia M, Bottcher C, Salomons FA, van Attikum H et al (2017) Ataxin-3
consolidates the MDC1-dependent DNA double-strand break response by
counteracting the SUMO-targeted ubiquitin ligase RNF4. EMBO J 36:
1066 – 1083
Pinato S, Scandiuzzi C, Arnaudo N, Citterio E, Gaudino G, Penengo L (2009)
RNF168, a new RING finger, MIU-containing protein that modifies
chromatin by ubiquitination of histones H2A and H2AX. BMC Mol Biol 10: 55
Puumalainen MR, Lessel D, Ruthemann P, Kaczmarek N, Bachmann K,
Ramadan K, Naegeli H (2014) Chromatin retention of DNA damage
sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity.
Nat Commun 5: 3695
Ramadan K (2012) p97/VCP- and Lys48-linked polyubiquitination form a new
signaling pathway in DNA damage response. Cell Cycle 11: 1062 – 1069
Rao MV, Williams DR, Cocklin S, Loll PJ (2017) Interaction between the AAA(+)
ATPase p97 and its cofactor ataxin3 in health and disease: nucleotide-
induced conformational changes regulate cofactor binding. J Biol Chem
292: 18392 – 18407
Ritz D, Vuk M, Kirchner P, Bug M, Schutz S, Hayer A, Bremer S, Lusk C, Baloh
RH, Lee H et al (2011) Endolysosomal sorting of ubiquitylated caveolin-1
is regulated by VCP and UBXD1 and impaired by VCP disease mutations.
Nat Cell Biol 13: 1116 – 1123
Sellou H, Lebeaupin T, Chapuis C, Smith R, Hegele A, Singh HR, Kozlowski M,
Bultmann S, Ladurner AG, Timinszky G et al (2016) The poly(ADP-ribose)-
dependent chromatin remodeler Alc1 induces local chromatin relaxation
upon DNA damage. Mol Biol Cell 27: 3791 – 3799
Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, Livingston DM,
Greenberg RA (2007) RAP80 targets BRCA1 to specific ubiquitin structures
at DNA damage sites. Science 316: 1198 – 1202
Stewart GS, Stankovic T, Byrd PJ, Wechsler T, Miller ES, Huissoon A, Drayson
MT, West SC, Elledge SJ, Taylor AM (2007) RIDDLE immunodeficiency
syndrome is linked to defects in 53BP1-mediated DNA damage signaling.
Proc Natl Acad Sci USA 104: 16910 – 16915
Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, Nakada
S, Ylanko J, Olivarius S, Mendez M et al (2009) The RIDDLE syndrome
protein mediates a ubiquitin-dependent signaling cascade at sites of DNA
damage. Cell 136: 420 – 434
Strickfaden H, McDonald D, Kruhlak MJ, Haince JF, Th’ng JP, Rouleau M,
Ishibashi T, Corry GN, Ausio J, Underhill DA et al (2016) Poly(ADP-ribosyl)
ation-dependent transient chromatin decondensation and histone
displacement following laser microirradiation. J Biol Chem 291: 1789 – 1802
Sy SM, Jiang J, Dong SS, Lok GT, Wu J, Cai H, Yeung ES, Huang J, Chen J, Deng
Y et al (2011) Critical roles of ring finger protein RNF8 in replication stress
responses. J Biol Chem 286: 22355 – 22361
Thorslund T, Ripplinger A, Hoffmann S, Wild T, Uckelmann M, Villumsen B,
Narita T, Sixma TK, Choudhary C, Bekker-Jensen S et al (2015) Histone H1
couples initiation and amplification of ubiquitin signalling after DNA
damage. Nature 527: 389 – 393
Vaz B, Halder S, Ramadan K (2013) Role of p97/VCP (Cdc48) in genome
stability. Front Genet 4: 60
Vaz B, Popovic M, Newman JA, Fielden J, Aitkenhead H, Halder S, Singh AN,
Vendrell I, Fischer R, Torrecilla I et al (2016) Metalloprotease SPRTN/DVC1
orchestrates replication-coupled DNA-protein crosslink repair. Mol Cell 64:
704 – 719
Wang Q, Li L, Ye Y (2006) Regulation of retrotranslocation by p97-associated
deubiquitinating enzyme ataxin-3. J Cell Biol 174: 963 – 971
Wang B, Elledge SJ (2007) Ubc13/Rnf8 ubiquitin ligases control foci formation
of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.
Proc Natl Acad Sci USA 104: 20759 – 20763
Watanabe S, Watanabe K, Akimov V, Bartkova J, Blagoev B, Lukas J, Bartek J
(2013) JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-
mediated chromatin response to DNA breaks. Nat Struct Mol Biol 20:
1425 – 1433
Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, Williams AJ, Cohen RE,
Peng J, Paulson HL (2008) The deubiquitinating enzyme ataxin-3, a
polyglutamine disease protein, edits Lys63 linkages in mixed linkage
ubiquitin chains. J Biol Chem 283: 26436 – 26443
Ye Y, Meyer HH, Rapoport TA (2003) Function of the p97-Ufd1-Npl4 complex
in retrotranslocation from the ER to the cytosol: dual recognition of
nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell
Biol 162: 71 – 84
Zhang S, Zhou Y, Sarkeshik A, Yates JR III, Thomson TM, Zhang Z, Lee EY, Lee
MY (2013) Identification of RNF8 as a ubiquitin ligase involved in
targeting the p12 subunit of DNA polymerase delta for degradation in
response to DNA damage. J Biol Chem 288: 2941 – 2950
Zhao Y, Mudge MC, Soll JM, Rodrigues RB, Byrum AK, Schwarzkopf EA,
Bradstreet TR, Gygi SP, Edelson BT, Mosammaparast N (2018) OTUD4 is a
phospho-activated K63 deubiquitinase that regulates MyD88-dependent
signaling. Mol Cell 69: 505 – 516 e5
Zhong X, Pittman RN (2006) Ataxin-3 binds VCP/p97 and
regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15:
2409 – 2420
Zhou HJ, Wang J, Yao B, Wong S, Djakovic S, Kumar B, Rice J, Valle E, Soriano
F, Menon MK et al (2015) Discovery of a first-in-class, potent, selective,
and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083). J Med
Chem 58: 9480 – 9497
Zhu Q, Sharma N, He J, Wani G, Wani AA (2015) USP7 deubiquitinase
promotes ubiquitin-dependent DNA damage signaling by stabilizing
RNF168. Cell Cycle 14: 1413 – 1425
Zimmer J, Tacconi EMC, Folio C, Badie S, Porru M, Klare K, Tumiati M,
Markkanen E, Halder S, Ryan A et al (2016) Targeting BRCA1 and BRCA2
deficiencies with G-quadruplex-interacting compounds. Mol Cell 61:
449 – 460
Zong D, Adam S, Wang Y, Sasanuma H, Callen E, Murga M, Day A, Kruhlak
MJ, Wong N, Munro M et al (2019) BRCA1 haploinsufficiency is masked by
RNF168-mediated chromatin ubiquitylation. Mol Cell 73: 1267 – 1281
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
ª 2019 The Authors The EMBO Journal e102361 | 2019 25 of 25
Abhay Narayan Singh et al The EMBO Journal
